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University of Connecticut, 2015 
Motile cilia and flagella are essential to many biological functions that require 
cellular or fluid movement. The motility of cilia and flagella in turn is dependent 
upon the action of large protein complexes that serve as molecular motors. Such 
axonemal motors are composed of multiple dyneins assembled in the cytoplasm 
of cells with motile cilia.  The mechanisms underlying this assembly are not fully 
understood. Fortuitously, we found that genetic deletion of exons 2–4 of Dyx1c1 
in mice caused a phenotype resembling Primary Ciliary Dyskinesia (PCD), a 
disorder characterized by chronic airway disease, laterality defects and male 
infertility. Ultrastructural and immunofluorescence analyses of Dyx1c1-mutant 
motile cilia in mice showed disruptions of outer and inner dynein arms (ODAs 
and IDAs, respectively). Dyx1c1 localizes to the cytoplasm of respiratory 
epithelial cells. Its interactome is enriched for molecular chaperones, and it 
interacts with the cytoplasmic axonemal motor assembly factor DNAAF2 (KTU) 
as well as transition zone protein Septin2. Additionally, a missense mutation in 
DYX1C1 found to lead to PCD in humans exhibits a weaker interaction of 
DYX1C1 with Sept2 and KTU and has reduced activity in promoting association 
of dyneins. These findings suggest that Dyx1c1 (DNAAF4) plays a role in dynein 
arm assembly or trafficking and when mutated leads to primary ciliary dyskinesia 
with laterality defects. Dyx1c1 interacts with intermediate and light chain subunits 
of the dynein arm complex in the cytoplasm of tracheal epithelial cells. Light and 
intermediate chains fail to form complexes in the cytoplasm of tracheal epithelial 
cells of Dyx1c1 mutants. Dyx1c1 increases by four fold the association of light 
chain subunits Dnal1 and Dnal4 in heterologously expressing HEK 293-T cells. 
Finally, a missense mutation in Dyx1c1 (p.L19Q) which cause PCD in humans is 
impaired in its ability to assembly Dnal1 and Dnal4. In conclusion, we identify a 
step in axonemal dynein pre-assembly in which Dyx1c1 facilitates formation of 
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1.1.1 History of the Cilium 
 
Cilia are the oldest known organelles, the discovery of which dates back to over 
three centuries. In September 1965, Anton Van Leeuwenhoeck, the father of 
microscopy, used a simple mounted lens and first described the cilia as “thin feet 
or little legs that moved very nimbly”. The term ‘cilia’ meaning eyelash, was 
however coined in 1786 by O.F. Muller1. The ciliary motility was the first function 
that was ever described.  The most common organisms to study this motility 
were ciliated protozoa, the clam gill, spermatozoa and the ciliated epithelia of 
vertebrates. On June 28, 1978, Leeuwenhoeck wrote: “One can’t be satisfied 
with just looking at so wonderful a structure, chiefly because one can’t get clear 
on how such an unbelievable motion is brought about..”2; thus posing the 
question: how do cilia work? Since then studies have focused on the biology of 
the ciliary assembly and motility giving us insights about the function, categories 
as well as ultrastructure of this organelle.  
1.1.2 Cilia structure  
 
Cilia and flagella are structures that project outward from the cell surface and 
have important sensory and motile functions. They are composed of a 
microtubule-based axoneme that is generated from a modified centriole called a 
basal body. The axoneme is surrounded by a specialized plasma membrane that 
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is continuous with the plasma membrane of the cell body. At the distal end of the 
basal body is the transition zone, where the triplet microtubule basal body 
extends into the doublet microtubule axoneme. Transition fibers link the transition 
zone of the centriole to a specialized region of the plasma membrane called the 
“ciliary necklace”3. It has been proposed that this region acts similar to the 
nuclear pore complexes of the nuclear envelope to selectively allow transport in 
and out of the ciliary compartment (Fig 1-1).   
 
 
All cilia are composed of a central microtubular scaffold, an intraflagellar 
transport (IFT) system, and transmembrane proteins. The basal body, a root-like 
 
Figure 1-1 Schematic of the ultrastructure of cilia.  Cilia consist of a microtubular 
scaffold that is connected to the cell via basal bodies. The region between the basal 
bodies and the base of the microtubules is called the transition zone that functions as 
trafficking region for the entry and exit of proteins. The apparatus is ensheathed in an 
extension of the plasma membrane, known as the ciliary membrane.  
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structure comprised of microtubule triplets, acts as a template for the ciliary 
ultrastructure. It is known that the basal bodies originate from the mitotic 
centriole. In cells with a primary cilium, the mother centriole migrates to the 
surface and, upon docking to the cell membrane, becomes known as the basal 
body4,5.  In multiciliated cells however, the centriole is thought to first differentiate 
and multiply before their migration to the apical cell surface3,6-8. The mechanism 
of this duplication of the centriole has recently spurred a lot of interest in ciliary 
research.  
1.1.3 Classification of cilia 
 
The microtubules are arranged as nine outer doublets consisting of a complete 
A-tubule and a fused incomplete B-tubule. These 9 doublets are connected to 
each other via nexin links. In primary cilia, the central microtubules are arranged 
as doublets in a 9+0 arrangement, whereas in motile cilia they are usually 
arranged in a 9+2 arrangement9. However, there are some motile cilia where the 
microtubules are in a 9+0 arrangement. Cilia are commonly grouped into two 
broad classifications: motile and non-motile cilia10,11 (Fig 1-2).  
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1.1.3.1 Motile Cilia  
 
Motile cilia generally have a “9+2” structure, which refers to the nine doublet 
microtubules and a central pair that make the axoneme. The nine outer doublets 
are composed of A and B subfibers that are connected by nexin linkages. In 
addition to the two central singlets, motile cilia also contain outer dynein arms 
(ODA), inner dynein arms (IDA) and radial spokes along their length. The above 
three structures are critical for the motility of the cilia. The movement occurs due 
to the sliding of the microtubule doublets past each other in the presence of ATP. 
The ODAs are known to be responsible for the ciliary beat generation while the 
IDA and radial spokes regulate the beat waveform or pattern. Motility is conferred 
Figure 1-2 Classification of cilia: Cross-section of non-motile (9 + 0 arrangement) and 
motile cilia (9 + 2 and 9 + 0 arrangement) is shown.  
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by the sliding of doublet microtubules relative to each other and this requires the 
central pair microtubules, outer and inner dynein arms that project from the A 
tubule and reversibly bind the neighboring B-tubule, and by radial spokes that 
connect the A tubule of the outer doublet to the central pair12-14.  
 
In mammals, motile cilia are found on cells of the airway epithelium, brain 
ventricles, oviduct, sperm and embryonic node. Each of these, with the exception 
of sperm and the ciliated cells of the embryonic node, possesses hundreds of 
motile cilia, and their coordinated beating is vital for movement of fluid and 
particles over the surface of the epithelium. In the node, motile cilia are unique in 
that they lack a central pair (“9+0” motile cilia) but are able to rotate due to the 
activity of ciliary dynein, and this movement generates nodal flow that it critical 
for the establishment of left-right asymmetry15. The rotational motion allows the 
cilia to move morphogens in developing tissue. Nodal cilia defects are associated 
with left-right asymmetry and developmental defects16,17.  
 
1.1.3.2 Non-motile cilia 
 
The “9+0” primary cilium is distinct from the motile cilium in that it lacks a central 
pair and the dynein arms required for ciliary motility, and only one is found per 
cell. Primary cilia have been found on almost every cell in the human body with 
the exception of the myeloid and lymphoid lineages. Once thought to be vestigial, 
primary cilia are now known to be important for detecting chemical and 
mechanical stimuli. Examples of specialized types of cilia are the olfactory 
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receptor cilium, mechanosensing cilia in the kidney tubule epithelium and in 
bone, and the connecting cilium of photoreceptor sensory neurons. In addition, 
important developmental signaling pathways such as Sonic hedgehog, platelet-
derived growth factor receptor (PDGFR) alpha, polycystin and Wnt are 
transduced through primary cilia. Kinocilia are microtubule-based ciliary 
structures that contain a motile cilia-like ultrastructure but are not motile. These 
cilia of the inner ear are thought to play a role in the planar cell polarity of the 
stereocilia18.  
 
1.1.4 Cilia formation and basal body generation 
 
Vertebrate ciliogenesis was first described by electron microscopy (EM) 
examination of ciliated tissues such as the multiciliated epithelia of rat airway 
epithelium8.  The early studies described ciliogenesis as proceeding in a series of 
steps: 1) cytoplasmic generation of basal bodies, where they acquire 
appendages required for basal body function, 2) basal body migration to the 
surface of the cell, where vesicles fuse with the plasma membrane, allowing the 
basal body to dock 3) and ciliary membrane growth and axoneme extension from 
the basal body. How ciliary length is then maintained is not well characterized in 
vertebrates, but in Chlamydomonas, this is achieved by balanced rates of 
assembly and disassembly6,19,20.  
 
Different pathways exist for the generation of basal bodies. In cells that make a 
single cilium, the basal body derives from the mother centriole, which is 
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duplicated according to the canonical centrosome cycle of dividing cells. In cells 
that make multiple cilia, basal bodies are generated according to two 
mechanisms: the canonical templated pathway and the acentrosomal non-
templated pathway. In the non-templated pathway, basal bodies arise de novo, 
multiple basal bodies grow from an electron-dense mass termed the 
deuterosome, which are present in multiples in the cytoplasm. In the template 
pathway, a single centriole grows off the side of a pre-existing mother centriole in 
the cytoplasm21,22. Another difference is that centriole duplication and maturation 
occurs during G0 in multiciliated cells, which are terminally differentiated, 
whereas in most cells in the body centrioles are duplicated once per cell cycle 
and only in S-phase, and mature later in the cell cycle. Several studies have 
identified that cilia are only observed in quiescent cells, or in cells that are in the 
G0-G1 phase of the cell cycle. Furthermore, when the cell divides, the cilia must 
be resorbed to free up the centriole for the mitotic spindle23-26. Post-division, the 
centriole once again becomes a basal body, leading to ciliogenesis. The ability of 
the cells to not undergo cell division in the presence of the cilium raises the 
possibility of cilium as a cell division checkpoint organelle18. 
 
1.1.5 Intraflagellar Transport 
 
Protein synthesis does not occur inside the cilium, so components for cilia growth 
and function are trafficked there. This is achieved by intraflagellar transport (IFT), 
which was first identified in the unicellular flagellated algae Chlamydomonas 
reinhardtii. IFT particles consist of “core” structural protein complexes, molecular 
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motors and adaptor proteins, and there are two types of IFT: anterograde and 
retrograde. In vertebrates, the anterograde IFT complex consists of IFT particles 
B and the microtubule plus-end directed kinesin-II complex consisting of KIF3A, 
KIF3B and KAP. Retrograde IFT complexes consist of IFT particles A and 
cytoplasmic dynein 2. IFT complex B and A are composed of at least 10 and 6 
proteins, respectively, and are thought to facilitate cargo transport through 
interaction with protein binding domains 27. Accumulations of IFT particles have 
been detected at transition fibers, leading to the hypothesis that docking at the 
transition zone might also be an important regulatory step for transport in and out 
of the cilium 28-31.  
 
1.2 MOTILITY OF CILIA 
 
Within the ciliary axoneme, multi-protein complexes exist by interconnecting the 
different components like the radial spokes, nexin links, central sheath and 
dynein arms. The dynein arms are attached to the peripheral microtubules with 
certain periodicity and are known to generate motility by ATP-dependent 
mechanism. The dynein arms are large, multi-subunit complexes assembled with 
polypeptides of different sizes: heavy chain (HC of 400-500 KDa), intermediate 
chain (IC of 45-110 KDa) and light chains (LC of 8-55 KDa). The ATPase activity, 
that provides the energy to produce the sliding movement between the 
microtubules resulting in ciliary beating, resides in the HC molecules. The motility 
of the dynein arms requires the orchestrated functioning of many dynein 
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components32,33.  
Studies have identified aberrant motility in Chlamydomonas strains. By 
mutational analysis, a number of axonemal dyneins have been identified and 
these studies indicate that 30-40 axonemal dyneins (14 HC, 7 IC and 15 LC) 
combine to form the dynein arms. There are two general types of dyneins built 
into motile axonemes: the outer-arm dyneins found towards the outside of the 
axoneme, and inner-arm dyneins, which are positioned closest to the central-
apparatus radial spokes12,14,32,34,35. The docking complex that attaches the outer 
arm (ODA-DC) is composed of three polypeptides, whereas the one for the inner 
arm has not yet been solved.  
1.2.1 Outer Dynein Arms 
 
Functional analysis has revealed that the outer arms provide about 80% of the 
power generated during ciliary beating. Cilia that lack ODAs beat significantly 
more slowly than wild type and thus defects in the outer arms are a major cause 
of primary ciliary dyskinesia (PCD) in humans. In all organisms examined to date, 
outer arms contain multiple either two (e.g. mammals and sea urchins) or three 
(e.g. Chlamydomonas and Tetrahymena) HCs associated with two WD-repeat 
ICs, a core set of LCs, and coiled-coil proteins involved in assembly within the 
axoneme. Most of the homologous genes encoding axonemal polypeptides in 
mammals have been identified. Furthermore, outer arms contain additional 
components that act in various signaling pathways to control motor function. 
Literature suggests that outer-arm dyneins contain a system that senses 
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mechanical strain and allows the motors to compensate for increased load33,36.  
ODA in eukaryotic cilia/flagella is a multimeric complex that is composed of 
heavy chains (HCs) that contain ATPase/motor domains, intermediate chains 
(ICs), and several light chains (LCs). The structure, subunit composition, and 
regulation of ODA are best studied using the green alga Chlamydomonas 
reinhardtii because numerous mutants with defects in the ODA subunit genes 
have been isolated. In Chlamydomonas, three HCs are bound like a bouquet, 
and two ICs and several LCs form a complex at the base of the bouquet (IC-LC 
complex) (Fig. 1-3a). The exceptions are LC1, LC3, LC4, and LC5, which are 
bound to either the motor domains or N- terminal regions of the HCs. The 
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ODAs are arranged linearly on specific sites of the A-tubule of doublet microtu- 
bules with a regular spacing of 24 nm, through interaction with the outer-dynein- 
arm docking complex (ODA-DC). The ODA-DC was first identified as a projection 
on the ODA-lacking mutants in Chlamydomonas. Biochemical and genetic 
analyses revealed that ODA-DC is composed of three subunits (termed DC1, 
DC2, and DC3). The subunit composition of ODA-DC in other organisms is 
different from that in Chlamydomonas. In humans, DC1 does not appear to be 
conserved but two genes seem to be DC2 orthologs36-40.  
 
Figure 1-3: Composition of the outer dynein arm. (a) In mammals, the outer dynein 
arm comprises of two heavy chains, two intermediate chains and about ten light 
chains. (b) The individual outer dynein arm subunit composition. (Adapted from 
Fliegauf et al. 2008) 
	  	   12 
1.2.2 Inner Dynein Arms 
 
In contrast to the outer dynein arm, which is homogeneous in composition and 
organization; genetic, biochemical, and structural analysis in Chlamydomonas 
have revealed seven major species of inner-arm dyneins: a, b, c, d, e, f (I1 
dynein), and g, and at least three minor species of inner-arm dyneins: DHC3, 
DHC4, and DHC11. 
Based on genomic and structural analyses, the organization and complexity of 
the inner dynein arms and 96 nm axonemal repeat was shown to be a highly 
conserved feature of all motile axonemes36,41-44. The complete composition as 
well as the predicted schematic of the IDA is presented in Fig. 1-4. Biochemical 
studies have revealed that certain dyneins within the flagellum act as monomeric 
motors and have a distinct complement of associated proteins including actin and 
either an essential LC (termed p28 in Chlamydomonas) or the calcium-binding 
calmodulin homolog centrin. Dimeric inner dynein arm contains two distinct HC 
motors and plays a key role in the regulation of axonemal motility. Mutants that 
lack this dynein exhibit slow swimming due to alterations in flagellar waveform 
that result in a less efficient beat. There is one copy of the IDA located within 
each 96 nm axonemal repeat and both HCs are necessary for its 
assembly32,35,45,46. 
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1.2.3 Ciliary beat generation 
 
The ODAs are responsible for the beat frequency and power required for 
generation of normal axonemal motility, whereas the inner-arm dyneins regulate 
the size and shape of the axonemal bend, parameters that are referred to as 
“waveform”. The beat pattern of motile cilia consists of an effective stroke and a 
 
Figure 1-4: Schematic of the inner dynein arm and their subunit composition. Inner 
dynein arm could consist of either one or two heavy chains, three or more 
intermediate chains and three or more light chains. The detailed structure of the inner 
dynein arms is not yet identified completely. The known subunit composition of the 
inner dynein arms is shown in the bottom panel. (Adapted from Fliegauf et al. 2008) 
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recovery stroke. The effective stroke is established when the cilia bend and move 
in a vertical manner, and this movement is mediated by the ODA12,34,47. During 
the recovery stroke, the cilia are found to travel in the horizontal direction 
respective to the fluid flow. Thus, the motion of motile cilia results in a net 
transport of particles in a single direction, a property that is essential especially 
for the effective clearance of particulates from the airway. 
 
As discussed briefly above, literature has revealed that the basis for ciliary 
motility lies in controlled dynein-driven microtubule sliding-a "sliding microtubule" 
model for ciliary bending (Fig. 1-5) 48-50. In addition, it was determined that the 
dynein motors generate force in one direction (minus-end direction) relative to 
microtubule polarity48,51. Thus, since all dyneins are minus-end motors, this 
observation directly led to a "switching" model for alternating effective 
(principal/forward) and recovery (reverse) bending: dyneins on one side of a 
structural and functional axis of the axoneme are active for bending in one 
direction. When the direction of bending changes or "switches", there is a switch 
in activity where the previously inactive dyneins, on one side of the axis, are 
activated, and the formerly active dyneins on the opposite side, are turned off.  
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The precise mechanism for sensing the end point of each bend direction is not 
understood but clearly for oscillatory bending, dynein motors must be regulated. 
Detailed experimental evidence indicates the basic oscillatory movement, and 
"switches" in bend direction, are inherent properties of the dynein motors 
involving microtubule curvature and a mechanical feedback control (Fig. 1-6) 
50,52-54. The switching sensor is not known, but one model includes the outer 
 
Figure	  1-­‐5:	  Sliding	  model	  of	  microtubule	  doublets. Bending of a cilium involves ATP-
dependent walking of motor domains of A-tubule dynein arms along adjacent B 
tubules, toward the minus end. This causes the sliding of microtubule doublets. Minus 
ends are anchored in the basal body, and flexible links between doublets (radial 
spokes and nexin links) limit sliding. The result is bending of the cilium. (Adapted from 
https://www.rpi.edu/dept/bcbp/molbiochem/MBWeb/mb2/part1/kinesin.htm) 
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dynein arm playing a role as a sensor of microtubule curvature53,55. 
 
1.2.4 Molecular Pathways of Axonemal Dynein Assembly and Transport 
 
Although axonemal dyneins function in cilia/flagella, these complex multi-
component enzymes are assembled in the cytoplasm and then transported into 
the cilium. Initial evidence for this came from the analysis of the assembly state 
of outer-arm dynein components in the cytoplasm of Chlamydomonas mutants 
Figure	  1-­‐6:	  Schematic	  of	  power	  stroke. The power stroke of the motor protein, dynein, 
attached to one microtubule, against subfiber B of a neighboring microtubule causes 
the fibers to slide past each other. The flexible linker protein, nexin, converts the 
sliding motion to a bending motion. (Adapted from 
http://www.arn.org/docs/behe/mb_mm92496.htm) 
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defective for various dynein proteins and assembly factors. The assembly of the 
outer-arm HCs and ICs with another HC was defective in the cytoplasm of strains 
lacking either the intermediate chains or the HCs56. In contrast, the core motor 
was completely assembled in the absence of the docking complex or ODA5 
proteins57. Oda7 is a Leucine rich repeat (LRR) protein that resides in the cell 
body and associates with both outer and inner arms. This protein possibly 
functions as a linker that joins these two dyneins arms together and is 
dissociated from the dynein complexes prior to their transport into the ciliary 
axoneme58,59.   
Additional cytoplasmic assembly factors for axonemal dyneins have recently 
been described; both are members of the PIH group, which interact with heat- 
shock family proteins. One protein encoded by the kintoun (ktu) gene was 
identified in medaka following a mutant screen and also in humans with PCD. In 
addition, the Chlamydomonas ortholog of Ktu, PF13 defects in which result in the 
failure of both outer and inner dynein arm assembly. The Ktu/PF13 protein was 
found to bind both dyneins and Hsp70, leading to the hypothesis that it acts as a 
co-chaperone to aid dynein assembly in cytoplasm60,61. A second PIH protein 
(MOT48) that is encoded at the IDA10 locus was identified as being required for 
the assembly of a subset of monomeric inner dynein arms. Bioinformatics 
analysis has identified additional PIH domain proteins in Chlamydomonas and 
indicates that these PIH proteins are present only in organisms that bear motile 
cilia. Furthermore, one of the uncharacterized Chlamydomonas PIH proteins 
appears to be homologous to the TWISTER protein in zebrafish defects in which 
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leads to polycystic kidneys and morphogenetic abnormalities61. An additional 
protein ODA16 in Chlamydomonas was revealed that is required for transport of 
outer-arm dyneins into the flagellum. This protein interacts directly with IFT46, 
which is part of the IFT complex B and is thought to act essentially as a cargo 




Inherited human mutations that result in the broad disruption of cilia cause 
severe developmental and adult phenotypes. Cilia are found on nearly every cell 
of the human body and are diverse in form and function.  Cilia function to clear 
mucus, move fluid, to sense fluid flow and other mechanical forces, to intercept 
extracellular signaling molecules and to concentrate and activate intracellular 
signaling molecules. Cilia participate in developmental processes from breaking 
the left-right symmetry of the embryo to tooth formation, and in adult processes 
ranging from kidney tubule homeostasis to vision, olfaction, and hearing. 
Mutations could affect a gene that disrupts an isolated cilia function and thus 
cause a mild disease like retinal degeneration, or they could affect a gene 
essential for all cilia functions and thus cause severe disease in all tissues where 
cilia are found and result in embryonic lethality. Collectively, diseases or 
developmental defects caused by an underlying defect in the assembly or 
function of 9+2 or 9+0 cilia, or both, are termed ciliopathies11,63.  
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1.3.1 Primary cilia-related ciliopathies 
 
Of the 80 genes now linked to ciliary diseases, nearly three-quarters of them are 
linked to cilia functions other than motility. Connecting cilia of retinal 
photoreceptors are essential for vision. Rhodopsin, as well other proteins, are 
produced in the inner segment of the photoreceptor and moved into the outer 
segment via intraflagellar transport along the microtubules of the connecting 
cilium. In the absence of this transport, photoreceptors die via apoptosis and the 
retina degrades, resulting in progressive loss of vision. Retinitis Pigmentosa and 
Leber Congenital Amaurosis are two types of retinal degeneration that have been 
linked to mutations in gene products associated with the cilium. RPGR (retinitis 
pigmentosa GTPase regulator) localizes to the connecting cilium of retina and 
mutations in the gene encoding it account for 20% of all retinitis pigmentosa 
cases. Interestingly, however, RPGR localizes to the transition zone of motile 
cilia in the trachea, and mutations in RPGR have been identified in PCD64. 
 
Autosomal dominant polycystic kidney disease (ADPKD), autosomal recessive 
polycystic kidney disease (ARPKD), and nephronophthisis (NPHP) are 
progressive cystic diseases of the kidney64-66. The genes mutated in ADPKD, 
ARPKD, and NPHP localize to the primary cilia lining the tubules of the kidney, 
where many cysts originate. This supports the hypothesis that cilia are involved 
in these diseases. Positional cloning revealed that the gene Ift88 was mutated in 
the Oak Ridge Polycystic Kidney disease mouse (Tg737orpk), a mouse model of 
ARPKD67,68. Two gene products polycystin-1, and polycystin-2, encoded by Pkd1 
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and Pkd2 respectively, are hypothesized to form a mechanosensory complex 
that can sense the bending of primary cilia in response to the flow of fluid in 
kidney tubules. The sensation of flow in the kidney tubule is required both for the 
proper formation of tubules during development, and for the maintenance of 
these tubules in adulthood. Mutation of Pkd1 or Pkd2 likely abolishes flow 
sensation and causes a compensatory proliferation or rearrangement of tubular 
cells. Mutation of Pkd1 or Pkd2 causes renal cystic disease due to the abolished 
flow sensation causing a rearrangement of tubular cells. Interestingly, a few 
genes, when mutated, can cause simultaneous cystic kidney disease and retinal 
degeneration, a condition known as Senior Løken syndrome18,24,66,69,70.  
 
Bardet-Biedl syndrome (BBS), Joubert syndrome (JS) and Meckel syndrome 
(MKS) are all multisystem, complex, recessively inherited human diseases, which 
display distinct but partially overlapping phenotypes. Common to these disorders 
are ocular/retinal abnormalities, polydactyly, renal cystic disease, CNS 
malformations or impairments, and situs inversus. Unique among these disorders 
is cognitive impairments and obesity in BBS, cerebellar vermis hypoplasia in JS 
and encephalocele and perinatal lethality in MKS. Genetically, there are 
numerous commonalities between JS and MKS, yet very little overlap between 
BBS and any other ciliopathy18,67,71-74. 
 
1.3.2 Motile cilia-associated ciliopathies 
 
Motile cilia play an important role during the development of, and in the 
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adulthood of, humans. The motile cilia of the node play a role in patterning the 
left-right axis of vertebrates, and thus mutations that affect cilia in this structure 
can result in situs inversus. Motile cilia with a 9+2 arrangement of microtubules 
are found in the ependymal cells of the brain, epithelial cells of the trachea and 
bronchioles, in sperm tails and throughout the female reproductive tract.  As 
discussed above, primary cilia dyskinesia (PCD), also known as Kartagener’s 
syndrome75, affects the motility of all cilia while leaving other functions intact. 
Afzelius predicted that the gene mutated in his Kartagener patients might encode 
the protein comprising the axonemal dynein arms that allow for the motility of cilia. 
Nearly every gene variant linked to Kartagener’s syndrome since then has been 
found to encode an axonemal dynein. However, recent studies have led to the 
identification of other genes apart from axonemal dyneins that are known to 
cause PCD76.  
 
The diseases associated with defects in motile cilia tend to be more 
straightforward due to the fact that motile cilia are primarily known for their role in 
fluid movement. Ciliary beat frequency (CBF) is probably the best-studied aspect 
of motile cilia biology, as defects in beating have numerous effects on human 
health. It has been known that CBF can change in response to exogenous 
signals. The many biological and chemical compounds that can affect CBF 
include prostaglandin, extracellular ATP, cytokines, cigarette smoke, ethanol and 
Vicks VapoRub77-81. Many neurotransmitters have been reported to modulate 
CBF, although the pathways are complex since effects seem to differ between 
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species. Recently it was found that motile cilia on mammalian airway epithelial 
cells are also sites for G-protein coupled receptor proteins, and that motile cilia 
alter their beating in response to exposure to bitter taste compounds82. Although 
the functions ascribed to motile cilia and primary cilia have historically been 
separate, this finding suggests that there may be more overlap than previously 
thought.  
1.3.3 Candidate PCD genes 
 
Dynein arm defects account for 90% of PCD cases with defined ultrastructural 
abnormalities. The newly discovered disease-causing gene mutations cause 
functional defects but are not associated with a consistent ultrastructural defect. 
Thus the presence of normal axonemal ultrastructure does not exclude PCD83. In 
addition to the identification of cilia-related proteins, advances in techniques of 
genetic screening and sequencing are leading the way for the use of genetic 
testing as a diagnostic tool84. PCD, an autosomal recessive disorder, is highly 
heterogenic owing to the large number of proteins involved in cilia assembly, 
structure, and function. A growing number of genes that are involved in axonemal 
motors, ciliary structure and regulation, or ciliary assembly and preassembly 
have been implicated in PCD (Table 1-1). 
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Table 1-1: Genes mutated in Primary Ciliary Dyskinesia (PCD). ODA: Outer 
Dynein Arm, IDA: Inner Dynein Arm, HC: Heavy chain, IC: Intermediate chain, LC: 
Light chain, CP: Central Pair, DRC: Dynein Regulatory Complex, and RSH: Radial 
Spokes.  
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The identification of PCD-associated genes has relied on a combination of 
experimental models, proteomic analysis, and sequencing of candidate genes. 
The best-studied model of motile cilia is the alga, C. reinhartii11,85. Screening 
algae with defective motility or abnormal flagellar structure has been used to 
study the function of orthologous ciliary proteins, which were linked to human 
diseases. The second major advance leading to PCD gene identification was the 
collection of ciliogenesis-related transcriptomes and cilia proteomes that provided 
lists of cilia genes that could be linked to newly found disease mutations86-89. 
More recently, parallel sequencing to analyze regions of interests in the genome 
has allowed more rapid identification of multiple new mutations in cohorts of PCD 
subjects without prior knowledge of candidate genes. In addition, whole-exome 
sequencing has the potential to unravel the genetic causes of rare diseases and 
was recently successfully used to identify new candidate genes associated with 
PCD11,90. 
 
To date, mutations in 19 different genes have been linked to PCD (Table 1-1), 
and more candidates are being verified. Early searches for PCD-related 
mutations identified genes that encode proteins integral to axonemal structure 
and function; outer dynein arm: DNAH5, DNAI1, DNAL1, DNAI2, TXNDC3, and 
DNAH1191-95; inner dynein arm and axonemal organization: CCDC39, CCDC40, 
CCDC16496-99; central apparatus and radial spokes: RSPH9, RSPH4A, and 
HYDIN100. More recently, mutations in several genes coding for several 
cytoplasmic proteins not found in the axoneme have been linked to PCD. These 
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proteins are presumed to have roles in cilia assembly or protein transport, and 
mutations lead to ultrastructural abnormalities: HEATR2, DNAAF1, DNAAF2, 
DNAAF3, CCDC103, LRRC6, and CCDC11460,101-106.  
 
Most PCD-causing mutations have been identified in components of the ciliary 
axoneme and mutations in two genes in particular, dynein axonemal intermediate 
chain 1 (DNAI1; MIM 604366) and dynein axonemal heavy chain 5 (DNAH5; MIM 
603335), which encode components of the outer dynein arm and account for 
more than 30% of all cases. DNAI1 was the first disease-associated gene to be 
identified using a candidate gene approach, by screening algae for abnormal 
flagellar beat and outer dynein arm defects. DNAI1 mutations were found in a 
large cohort at a prevalence of 9% of all identified PCD subjects. Mutations in 
DNAH5, another component of the outer dynein arm, were discovered using 
homozygosity mapping in large affected endogamous families, and later 
identified by sequencing in PCD subjects. Other examples of mutated axonemal 
proteins associated with PCD discovered using the candidate gene approach 
include intermediate dynein chain DNAI2 (MIM 605483), which comprise about 
2% of PCD patients, and TXNDC3 (MIM 607421). Mutations in the dynein 
axonemal heavy chain 11 (DNAH11; MIM 603339) gene, which encodes an outer 
dynein arm protein, are not associated with an ultrastructural defect and cilia 
have normal (or more rapid) beat frequency. Mutations in other genes, such as 
coiled-coil domain containing proteins CCDC39 (MIM 613798) and CCDC40 
(MIM 613799), produce inconsistent ultrastructural abnormalities characterized 
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by disordered microtubules in some but not all cilia.  
 
Several nonstructural cilia-associated proteins have been found to be mutated in 
PCD individuals and result in the absence of outer and inner dynein arms. These 
mutations involve proteins that are considered to function in cilia assembly or 
“preassembly” pathways. Identification of the involvement of these proteins has 
spurred research into the mechanisms of cilia biogenesis. To understand the role 
of these mutations, cilia biogenesis can be conceptually divided into the following 
processes: intra-axonemal transport, transfer into the cilium, and cytoplasmic 
preassembly. How specific proteins are coded for precise delivery and assembly 
within the cilium and how the transition zone acts as a gate is not yet known.  
1.3.3.1 PCD-causing preassembly proteins 
 
Several gene mutations in preassembly proteins have been found to cause PCD. 
The first PCD-associated preassembly protein found was DNAAF2 (MIM 613190), 
which was identified in mutant zebrafish and later in PCD subjects who had 
complete absence of outer dynein arms. Localized within the apical region of the 
cell cytoplasm, DNAAF2 belongs to the proteins interacting with Hsp90 family 
and interacts with DNAI2 and the chaperone heat shock protein HSP70 to 
facilitate assembly or dynein complex transport into the cilia60,61. Similar to 
DNAAF2, MOT48 is a protein interacting with Hsp90 localized in the cell body 
that was identified in the Chlamydomonas to display motility defects and is 
associated with preassembly of both outer dynein arms and a subset of inner 
dynein arms, likely needed for the stability of dynein heavy chain components61. 
	  	   27 
Mutations in the related proteins DNAAF1 (LRRC50; MIM 612517) and DNAAF3 
(MIM 614566) caused outer dynein arm defects in subjects with PCD. Evidence 
for assembly roles of these proteins is substantiated in mutant cells where 
components of the inner dynein arm were found to accumulate in the cytoplasm 
of mutated cells and fail to move into the cilium102,107. These findings indicate the 
existence of a multistep cytoplasmic assembly pathway. 
 
Another preassembly protein with mutations causative of PCD is HEATR2 (MIM 
614864), which was recently implicated in dynein arm assembly. Similar to other 
preassembly factors, HEATR2 is localized to the cytoplasm of ciliated cells rather 
than in the apical region, which suggests that it either functions at different 
stages of dynein assembly or is part of a chaperone complex that facilitates 
transfer of different dynein complexes along an “assembly line.” The finding that 
HEATR2 mutations are associated with mislocalization of inner arm proteins 
supported this role101.  
 
Mutations in LRRC6 (MIM 244400) also lead to PCD. A member of a protein 
family with diverse functions, including splicing factors and nuclear transport, 
LRRC6 is found in the cytoplasm and colocalizes with basal body markers. 
Mutations in LRRC6 were shown to downregulate expression of other dynein arm 
proteins and indicate an additional regulatory role108. Thus, dynein arm 
preassembly is intricately regulated by both positive and negative feedback 
mechanisms. 
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1.4 DYX1C1  
A candidate gene in DYX1, subsequently named DYX1C1, was first identified 
through studies of a Finnish family in which a chromosomal rearrangement, a 
translocation involving chromosomes 2 and 15, co-segregated with reading and 
writing difficulties109-111. The chromosome 15 breakpoint of this translocation was 
located within the DYX1 region that mapped to the DYX1C1 gene112.  
1.4.1 DYX1C1 and Neuronal Migration 
 
Wang and colleagues performed the first functional characterization of DYX1C1 
where they utilized in utero knockdown of the rodent ortholog, Dyx1c1, of this 
gene in the embryonic rat neocortex. This knockdown led to the abnormal 
neuronal migration in the rat neocortex stalling the neurons in the intermediate 
zone, thus leading to accumulation of neurons in the multipolar stage of 
migration114,124,125. The effects of the knockdown were non-autonomous and also 
disturbed some other neighboring cells in addition to the cells that had been 
knocked down for Dyx1c1126. Overexpression of Dyx1c1 rescued migration, 
confirming that the knockdown was causing the aberrant phenotype; and it was 
found that the TPR domains were sufficient for this rescue 124.  
1.4.2 DYX1C1 function and its known interactors 
 
DYX1C1 is a 420 amino acid protein that is expressed ubiquitously in adult 
tissues including brain. The protein can be detected by immunocytochemistry in 
the nuclei and cytoplasm of neurons and glia in human neocortex. The protein 
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domains of DYX1C1 include an N-terminal p23 and three C-terminal TPR 
domains112. This combination of a p23 and TPR domains is shared with Sugtl, a 
protein known to play a role in kinetochore assembly in yeast, suggesting a 
potential role in cell division or cell dynamics. DYX1C1, when over-expressed in 
cell lines, can interact with Hsp70, Hsp90 and an E-3 ubiquitin ligase, Chip, 
suggesting that DYX1C1 may also be involved in the degradation of unfolded 
proteins127,128. At its C-terminal, there are three tetratricopeptide domains (TPR) 
which function in protein-protein interactions. Studies have shown that the rat 
orthologue of DYX1C1 interacts with estrogen receptors in primary rat 
neurons129. It has been thus proposed that DYX1C1 negatively regulates 
estrogen receptor levels in a dose-dependent manner, decreasing their 
transcriptional activity and stability. Variants in the promoter region of DYX1C1 
have been suggested to mediate allele-specific binding of transcription factors 
(such as TFII-I and Sp1) and/or to be associated with different expression levels 
of the gene130. 
 
Follow-up study on the function of Dyx1c1 demonstrated that when neurons were 
subjected to embryonic knockdown of Dyx1c1 levels, they migrated past their 
expected laminar targets114. These over-migration observations have been 
confirmed in a subsequent investigation using live-cell imaging of human 
neuroblastoma cells, where knockdown of DYX1C1 led to increased migration 
rates compared with controls. This phenotype was dependent not only on the 
TPR domains but also on another novel highly conserved motif, referred to as a 
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DYX1 domain131. Analysis of changes in global gene expression levels after 
perturbation of DYX1C1, by overexpression or knockdown in these cell lines, 
uncovered a group of genes that was enriched for known functions, including 
‘cellular component movement’, ‘cell migration’, and ‘nervous system 
development’, as well as a pathway involved in focal adhesion131,132. Tammimies 
and colleagues specifically assessed whether DYX1C1 can interact with other 
proteins implicated in neuronal migration and/or associated with dyslexia 
susceptibility, including DCDC2 and KIAA0319. It was found that DYX1C1 
interacts with LIS1 (a protein implicated in lissencephaly, a rare brain disorder 
caused by severely disrupted neuronal migration) and DCDC2, but not with 
KIAA0319. Several new interactions with DYX1C1 were also reported, with a 
significant overrepresentation of proteins that are components of the 
cytoskeleton, three of which (TUBB2B, TUBA1, and Ataxin1) were further 
validated131. 
1.4.3 DYX1C1 and ciliary function 
 
The literature mining approach utilized by Ivliev and colleagues revealed that the 
consensus ciliary signature included the dyslexia candidate genes DYX1C1, 
DCDC2 and KIAA0319. This finding was however surprising since no role of cilia 
has been identified to date in dyslexia121. Primary cilia are present on the surface 
of neurons and hence cilia are implicated in early brain patterning and 
homeostasis. As discussed earlier, a study has shown that overexpression of 
DCDC2 in neurons changes the morphology and function of the primary cilium. In 
sum, these studies raise a possibility that ciliary dysfunction might be associated 
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with dyslexia.   
 
Recent work by Chandrashekar and colleagues demonstrated the developmental 
role of DYX1C1 using a zebrafish model. The zebrafish orthologue of DYX1C1 is 
expressed in many ciliated tissues, and its knockdown leads to multiple 
ciliopathy-related phenotypes such as body curvature, hydrocephalus, situs 
inversus and kidney cysts. The dyx1c1 morphants also exhibited reduced cilia 
length in several organs including Kupffer’s vesicle, pronephros, spinal canal and 
olfactory placode. Furthermore, electron microscopic analysis of cilia in dyx1c1 
morphants revealed loss of both outer (ODA) and inner dynein arms (IDA) that 
have been shown to be required for cilia motility. In sum, an essential role for 
dyx1c1 was proposed in cilia growth and function133.  
 
1.5 Overview 
Studies have been performed to evaluate the developmental role of Dyx1c1 in 
the brain due to its association with dyslexia. However, further characterization of 
the protein needs to be done to assess its role in development. A good approach 
to characterize the function of Dyx1c1 protein is to generate a transgenic mouse 
model that lacks the protein. The work herein highlights the role of Dyx1c1 in 
mouse development and disease. In chapter 2, I show that the Dyx1c1 protein is 
important for the function of motile cilia and the absence of Dyx1c1 leads to 
ciliopathy phenotypes of hydrocephalus and situs inversus. It is thus 
hypothesized to play a role in the assembly of the outer and inner dynein arms 
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that are responsible for the motility of the cilia.  
 
In chapter 3, I describe the localization and interactors (direct or indirect) of 
Dyx1c1 in order to evaluate its role in the ciliary dynein assembly process. With 
co-immunoprecipitation and mass spectrometric analysis, I found that Dyx1c1 
interacts with heat shock proteins Hsp70, Hsp90 as well as T-complex 
chaperones (CCTs). In addition to these proteins, an interesting interactor 
Septin2 was identified that has been previously shown to be a protein of the 
ciliary transition zone regulating the trafficking of proteins in and out of the cilium. 
These findings strengthen the hypothesis that Dyx1c1, a protein that localizes to 
the cytoplasm of ciliated cells, is required for the assembly and transport of the 
axonemal dyneins.  
 
In chapter 4, I describe a novel mutation that has been identified in Dyx1c1 that 
is known to cause PCD in Druze patient population. Using western blot analysis 
on the patients, I found that Dyx1c1 protein is expressed at the correct molecular 
weight in these patients. The interactions of Dyx1c1 with Ktu and Septin2 are 
reduced in the Dyx1c1 mutant condition, thus indicating a critical role of Dyx1c1 
in the ciliary dynein assembly process.  
 
In chapter 5, I identify the role of Dyx1c1 in the pre-assembly of axonemal 
dyneins. By co-immunoprecipitation and western blot analysis, I show that 
Dyx1c1 interacts with the outer dynein arm light chain subunits Dnal1 and Dnal4 
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as well as intermediate chain subunits Dnai1 and Dnai2. However, in the 
cytoplasm of the Dyx1c1 knockout tracheal epithelial cells, the interaction of 
Dnal1 and Dnal4 is markedly reduced indicating a role of Dyx1c1 in the assembly 
of these two proteins. Using a heterologous expression system, I show that 
Dyx1c1 is essential for the association of Dnal1 and Dnal4; and this interaction 
requires both the p23 and TPR domains of Dyx1c1.  
 
In chapter 6, I provide a summary of the work performed in this thesis. I will 
identify unanswered questions suggested by these works and propose follow up 
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2. CHARACTERIZATION OF THE DYX1C1 KNOCKOUT 
MOUSE 
 
2.1 Abstract  
Dyx1c1 was the first gene associated with dyslexia susceptibility (Taipale et al 
2003). While the results of RNAi experiments suggest a role in neuronal 
migration (Wang et al 2006), and protein interaction studies suggest possible 
roles in chaperonin function (Chen et al 2009) and estrogen receptor trafficking 
(Massinen et al 2009), a genetic test for the required functions of Dyx1c1 has 
been lacking. In order to elucidate the required functions of Dyx1c1, we have 
analyzed the phenotype of a Dyx1c1 knockout mouse in which exons 2,3 and 4 
were deleted. Western blot analysis confirmed that the mutation results in a 
complete loss of Dyx1c1 protein expression. In breeding experiments between 
heterozygous mice the ratio of homozygous KO, heterozygous, and WT mice 
was 1:4:2, indicating possible embryonic lethality. The surviving Dyx1c1 knockout 
mice display severe developmental abnormalities that include Situs Inversus, a 
reversal in the typical left-right asymmetry of thoracic and abdominal organs and 
early onset hydrocephaly. These two phenotypes are often associated with 
Primary Ciliary Dyskinesia in mice. We therefore examined cilia structure and 
motility in the ventricles of knockout mice.  Immunostaining for acetylated tubulin, 
and gamma tubulin indicated that the cilia of ependymal cells lining the lateral, 
third, and fourth ventricles were intact and not appreciably decreased in number.  
In contrast, live cell imaging and an Indian ink flow assay indicated a lack of 
ciliary motility.  In WT mice, a cilia beat frequency of 7.5 beats/second was 
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observed in lateral, third and fourth ventricles using DIC video microscopy of 
brain slices. However, in Dyx1c1 KOs cilia were completely immotile and 
displayed no apparent beating.  In an additional assay for the motility of cilia in 
the lateral ventricles a small volume of Indian ink was applied to the surface of 
the ventricle and the dispersion and flow of ink was imaged.  In wt mice an 
anteriorly directed flow was apparent with an approximate velocity of 96 mm/sec, 
while in the KO mice the Indian ink showed only a passive diffusion in all 
directions at a rate of 6 mm/sec. When the ultrastructure of the WT and KO cilia 
was examined, we found that the inner and outer dynein arms that are required 
for the ciliary motility were missing in the KO. In sum, the analysis of the Dyx1c1 




Cilia, hair-like organelles projecting from the surface of nearly all polarized cell 
types, serve essential roles in cellular signaling and motility. The basic structure 
of motile cilia and the related organelle flagella is evolutionarily conserved. In 
most motile cilia, a ring of nine peripheral microtubule doublets surrounds a 
central pair apparatus of single microtubules that connect to the nine peripheral 
doublets by radial spokes (9+2 structure). Motile monocilia present at the mouse 
node during early embryogenesis are an exception, lacking the central pair 
apparatus (9+0 structure)72,134. Distinct multi-protein dynein complexes attached 
at regular intervals to the peripheral microtubule doublets contain molecular 
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motors that drive and regulate ciliary motility. Specifically, ODAs are responsible 
for beat generation, whereas both the IDAs and the nexin link–dynein regulatory 
complexes (N-DRCs) regulate ciliary and flagellar beating pattern and frequency. 
Identifying the proteins responsible for the correct assembly of this molecular 
machinery is critical to understanding the causes of motile cilia–related 
diseases134.  
PCD (MIM 244400), a rare genetic disorder affecting approximately 1 in 20,000 
individuals, is caused by immotile or dyskinetic cilia. Loss of ciliary function in 
upper and lower airways causes defective mucociliary airway clearance and, 
subsequently, chronic inflammation that regularly progresses to destructive 
airway disease (bronchiectasis). Organ laterality defects are also observed, with 
approximately half of individuals with PCD exhibiting situs inversus and, more 
rarely, situs ambiguus, which can associate with complex congenital heart 
disease. Dysfunctional sperm tails (flagella) frequently cause male infertility in 
individuals with PCD. Another consequence of ciliary dysfunction, particularly 
evident in mouse models, is hydrocephalus caused by disrupted flow of 
cerebrospinal fluid through the cerebral aqueduct connecting the third and fourth 
brain ventricles. Although ciliary dysmotility is not sufficient for hydrocephalus 
formation in humans owing to morphological differences between the mouse and 
human brains, the incidence of hydrocephalus, secondary to aqueduct closure, is 
higher in individuals with PCD85,90,135.  
Genetic analyses of individuals with PCD have identified several autosomal 
recessive mutations in genes encoding axonemal subunits of the ODA 
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complexes and related components. In addition, recessive mutations in 
CCDC3996 (MIM 613798) and CCDC4097 (MIM 613799) have been linked to 
PCD with severe tubular disorganization and defective nexin links. Mutations in 
the radial spoke head genes RSPH4A and RSPH9 as well as in HYDIN can 
cause intermittent or complete loss of the central-apparatus microtubules135. Two 
X-linked PCD variants associated with syndromic cognitive dysfunction and 
retinal degeneration are caused by mutations in OFD1 (MIM 311200) and RPGR 
(MIM 312610), respectively. Another functional class of proteins emerging from 
the identification of PCD-causing mutations are proteins involved in the 
cytoplasmic preassembly of both ODAs and IDAs, including those encoded by 
DNAAF260 (also known as KTU; MIM 612517), DNAAF1104 (also known as 
LRRC50; MIM 613190), DNAAF3102 (also known as C19orf51; MIM 614566) and 
the recently identified LRRC6103 (MIM 614930).  
DYX1C1 (MIM 608706) was initially identified as a candidate dyslexia gene, 
owing to both a single balanced translocation t(2;15)(q11;q21) coincidentally 
segregating with dyslexia in a family and subsequent SNP association studies112. 
Follow-up gene association studies have provided both positive and negative 
support for association with dyslexia. Taipale et al. (2003) showed that DYX1C1 
is expressed nearly ubiquitously in adult tissues, including brain, and that the 
protein can be detected by immunocytochemistry in the nuclei and cytoplasm of 
neurons and glia in human neocortex. The protein domains of DYX1C1 include 
an N-terminal p23 and three C-terminal TPR domains. DYX1C1, when over-
expressed in cell lines, can interact with Hsp70, Hsp90 and an E-3 ubiquitin 
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ligase, CHIP, suggesting that the protein may also be involved in the degradation 
of unfolded proteins127,128. Wang and colleagues performed the characterization 
of the developmental function of DYX1C1 by employing in utero RNAi in 
embryonic rat neocortex. The results from this study indicate that DYX1C1 plays 
a role in the migration of neocortical neurons and more specifically is required for 
the transition out of the multipolar stage of migration. Dyx1c1 RNAi decreased 
the migration of neurons causing them to accumulate in a multipolar stage of 
migration. The impairment was rescued by overexpression of Dyx1c1, and the C-
terminal TPR domains were sufficient to rescue migration. Using truncation 
mutants, they found that the C-terminus of DYX1C1 biases the cellular 
localization of DYX1C1 to the cytoplasm, while the N-terminus alone can localize 
to the nucleus and cytoplasm in cell lines and in developing neurons124,125. 
Molecular and cellular analyses of DYX1C1 have indicated potential functional 
roles in estrogen receptor trafficking, and recent proteomic and gene expression 
studies have suggested a possible role in cilia121,129,133.  
 
2.3 RESULTS  
2.3.1 Generation of Dyx1c1-mutant mice  
 
To elucidate the biological functions of DYX1C1, we performed a forward genetic 
experiment by producing an allele of Dyx1c1 in mice in which exons 2–4 were 
deleted (Fig. 2-1a). Homozygous mutant mice (Dyx1c1∆/∆) expressed no 
detectable DYX1C1 protein by immunoblot analysis of all tissues tested, 
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including brain and lung (Fig. 2-2b).  
 
Mice heterozygous for the deletion allele were viable, fertile and not noticeably 
different from wild-type littermates. Homozygous mutant mice were recovered 
after birth from heterozygous breeding pairs at a rate deviating from the expected 
Mendelian ratio (295:570:87 for Dyx1c1+/+:Dyx1c1 ∆/+:Dyx1c1∆/∆, c = 128.017, 
P < 0.0001) but were recovered at early embryonic times (embryonic day (E) 
                               
Figure 2-1: Targeted Deletion of Dyx1c1 (a) Schematic of the strategy for 
producing the Dyx1c1 exon 2–4 deleted allele. A conditional knockout allele was 
inserted by homologous recombination and then exons 2–4 were deleted from the 
germline by breeding mice to an Hprt-Cre line of mice. (b) Left panel, PCR indicating 
the genotyping results from the wild-type (F1/R1, 437bp) and deleted alleles (F1/R2, 
356bp). Right panels, Western blots show the presence of Dyx1c1 protein detected in 
brain and lung of wild-type (Dyx1c1+/+), and heterozygous animals (Dyx1c1Δ/+), but 
missing from homozygous mutants (Dyx1c1Δ/Δ). 
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6.5–12) at the expected Mendelian ratio (22:43:20, c = 0.105, P = 0.85), 
suggesting embryonic lethality of approximately two-thirds of homozygous 
mutants (Fig. 2-2).  
 
Homozygous mutants that survived after birth developed severe hydrocephalus 
by postnatal day (P) 16 (Fig. 2-3) and died by P21, similar to what has been 
described for other mouse mutants with defective motile cilia3,39.  
 
Figure 2-2 Recovery rates of the Dyx1c1 animals at embryonic and postnatal 
timepoints. Graph shows the percentage survival of the wildtype, heterozygous and 
knockout animals. 
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In addition to hydrocephaly, postnatal homozygous mutant mice displayed 
laterality defects, with 59% of mutants (51/87) showing situs inversus totalis (a 
complete inversion of left-right asymmetry; Fig. 2-4), 17% (15/87) showing situs 
ambiguous with inverted heart and lung position relative to stomach and spleen 
or inverted stomach and spleen position relative to heart and lung, and 24% 
(21/87) showing situs solitus (normal left-right asymmetry).  
 
 
Figure 2-3: Dyx1c1 knockout mice exhibit hydrocephalus. Characteristic domed 
crown in Dyx1c1Δ/Δ mice develops by P16 with the ventricles seen in coronal sections 
are greatly expanded in Dyx1c1Δ/Δ relative to Dyx1c1+/+ mice. Scale bar, 250mm. 




Figure 2-4: Dyx1c1 knockout mice exhibits situs inversus. (a) Situs inversus in 
Dyx1c1Δ/Δ mice as seen in both the reversal of the milk filled stomach in neonates to 
the right side, and exposed viscera showing reversal of multiple organs including 
heart (He), stomach (St), and spleen (Sp). (b) Graph shows the organ symmetry of 
the knockout mice.  
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Mutations that cause disruptions in left-right asymmetry in mice40 are known to 
result from defects in the function of motile nodal monocilia and, more specifically, 
the loss of cilia-generated leftward flow across the node in early 
embryogenesis40. The typical phenotype for laterality mutants is a 1:1 ratio of 
situs inversus totalis and situs solitus, indicating a randomization of left-right 
patterning, although the inv mutant mouse has 100% of affected pups with situs 
inversus. Even if the ratio of situs inversus to situs solitus seen in surviving 
Dyx1c1-mutant mice deviates significantly from what would be expected for a 1:1 
ratio of situs inversus to situs solitus (51:21, c = 12.5, P = 0.0004), this ratio was 
already observed in other mutants for left-right patterning, such as in Dnahc5-
mutant mice41.  
 
2.3.2 Analysis of the nodal monocilia 
 
Consistent with a role for DYX1C1 function in the embryonic node where left-right 
patterning is established in the mouse, it has been found by whole-mount in situ 
hybridization that Dyx1c1 expression in the early embryo (E7.5) was restricted to 
pit cells of the embryonic node. Recently, it was shown that knockdown of 
dyx1c1 results in phenotypes characteristically associated with cilia defects, such 
as body curvature, hydrocephalus, cystic kidneys and situs inversus42. In 
zebrafish, dyx1c1 is expressed in embryonic tissues that contain motile cilia42, 
including Kupffer’s vesicle, which is known to have an important role in 
establishing the left-right axis. We investigated the mutant mouse embryo at E7.5 
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and found no striking structural abnormalities compared to the wildtype embryo. 
However when we assessed the mutant mouse node, we found that some 
vesicle like structures were present on the node in addition to the monocilia (Fig 
2-5). In contrast, the wildtype node did not show the presence of any vesicle like 
structures. The defective mouse node in the mutant could be due to the 
dysmotile cilia that cause aberrant flow of the extra-embryonic fluid containing 
morphogens required for the break of left-right asymmetry.   
 







Figure 2-5 Dyx1c1 knockout mouse node is abnormal. Top panel (a) 
shows the wildtype E7.5 mouse embryo (left panel) and mouse node (middle, 
right panel). Bottom panel (b) shows the knockout E7.5 mouse embryo (left 
panel) and mouse node (middle, right panel). Blue arrows point to the node; 
red arrows point to the cilia; and yellow arrows point to vesicle-like 
depositions.  
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2.3.3 Analysis of ependymal cilia  
 
Hydrocephalus and organ laterality defects are hallmarks of mutations that cause 
defects in ciliary motility in mice1,3. We therefore used light and electron 
microscopy as well as video-microscopy to determine whether DYX1C1 
deficiency caused loss of motile cilia formation or loss of cilia. Cilia extending 
from mouse ependymal cells of the cerebral ventricles, visualized by light 
microscopy, appeared similar in length and distribution in Dyx1c1∆/∆ and wild-
type littermates (Fig. 2-6a). When immunofluorescence analysis on the was 
performed to look for the any abnormalities of the lateral ventricles; we found that 
markers for cilia (acetylated tubulin), cell margins (beta catenin) and basal bodies 
(gamma tubulin) were present on lateral ventricles of Dyx1c1∆/∆ and wild-type 
littermates without any significant differences in structure (Fig 2-6b). 
 




Figure 2-6 Cilia are present on the brain ependymal surface of the Dyx1c1 
knockout mice. (a) H&E stained sections of the cerebral ventricles show the 
presence of cilia on the surface of the ependymal cells in both Dyx1c1+/+ and 
Dyx1c1Δ/Δ mice. (b) Immunofluorescence analyses of lateral ventricles stained for 
acetylated tubulin (green), and beta-catenin and gamma tubulin (red). 
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We used live-cell imaging to directly assess cilia-mediated fluid flow and ciliary 
motility on the ependymal surface in Dyx1c1∆/∆ mice. We prepared explants or 
slices of the lateral ventricular surfaces from Dyx1c1∆/∆ and wild-type mice at P6. 
Ependymal cilia in wild-type mice continued to beat vigorously in these 
preparations and created a directional fluid flow across the surface that could be 
visualized by the displacement of a small volume of India ink pressure-injected 
onto the ependymal surface. This flow was present in all wild-type mice tested (n 
= 6; Fig. 2-7a) but was completely absent in tissue obtained from all Dyx1c1∆/∆ 
mice tested (n = 4; Fig. 2-7b).  
We next examined the motility of ependymal cilia in coronal brain slices of wild-
type and Dyx1c1∆/∆ mice by infrared differential interference contrast (DIC) 
videomicroscopy. Cilia at the ependymal surface in wild-type and heterozygous 
mice (n = 8) were found to beat at a frequency of approximately 9 beats/s (34 °C), 
whereas cilia on ependymal cells from all Dyx1c1∆/∆ examined (n = 4) lacked 
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Figure 2-7: Motile cilia of the Dyx1c1 knockout mice are dysfunctional. (a) Flow 
of fluid (Indian ink) across the ependymal surface in brain ventricle cup preparations 
from a Dyx1c1+/+ and Dyx1c1Δ/Δ at mice P6. Directional flow was rapid across the 
surface of Dyx1c1+/+ ependymal epithelia, while only non-directional passive diffusion 
was observed on ependymal surfaces in Dyx1c1Δ/Δ. The starting point for the fluid is 
at the end of the pipette tip, seen bottom right. (b) Snapshots of the cilia motility in 
wildtype (top panel) and knockout (bottom panel). The right panel shows the 
displacement of the cilia. 
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2.3.4 Analysis of Dyx1c1-mutant respiratory cilia  
 
To assess the ultrastructure of respiratory cilia in mutants, we obtained 
transmission electron micrographs of tracheal cilia. As on the ependymal surface, 
tracheal cilia were abundant in both wild-type and Dyx1c1∆/∆ epithelial cells (Fig. 
2-8a), but, unlike tracheal cilia in wild- type mice, cilia in the Dyx1c1∆/∆ trachea 
were surrounded by cellular debris and mucus (Fig. 2-8a). We further examined 
the ultrastructure of tracheal cilia in cross-sections by transmission electron 
microscopy (TEM). Using TEM, we observed that tracheal and brain ependymal 
cilia in wild-type and mutant mice had typical 9+2 microtubular structure with 
intact radial spokes (Fig. 2-8b). In contrast, cilia in Dyx1c1∆/∆ mice lacked both 
ODA and IDA structures in respiratory cilia (Fig. 2-8b). Thus, the phenotype 
caused by loss of function of Dyx1c1 is a severe ciliary motility defect associated 
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2.4 Discussion 
Dyx1c1 was previously identified as a candidate dyslexia susceptibility gene that 
plays an important role in the neuronal migration124. Studies performed to 
characterize the molecular function of Dyx1c1 in zebrafish showed that Dyx1c1 
has a role in ciliary function133. Here we explore the role of Dyx1c1 during 
development, for which we generated a transgenic mouse wherein the exons 2,3 
and 4 of the Dyx1c1 gene are deleted. The Dyx1c1 knockout mouse thus 
Figure 2-8: Dyx1c1 knockout motile cilia lack outer and inner dynein arms. (a) 
TEM images of cross-sections through the trachea of wild-type and Dyx1c1Δ/Δ. 
Abundant cilia were present in each, but cilia structures (red arrows) in the Dyx1c1Δ/Δ 
trachea are surrounded by cellular debris and mucus. (b) TEM cross-section images 
of ependymal and tracheal cilia in Dyx1c1+/+ and Dyx1c1Δ/Δ mice. The 9+2 
microtubular structure was well preserved in Dyx1c1Δ/Δ, except that the outer and 
inner dynein arms were lacking in tracheal cilia. The scale bars represent in (a) 1µm 
(left panel) and 2µm (right panel) and in (b) 0.1 µm. 
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generated was verified by genotyping to confirm the deletion of the exons 2,3 
and 4. We further performed western blot analysis on the protein lysates 
obtained from the brain and lung tissues of the Dyx1c1 wildtype, heterozygous 
and knockout mice. We observed that the Dyx1c1 protein was detected at the 
molecular weight of 48KDa in the WT as well as heterozygous animals, however 
the KO mice lacked the expression of Dyx1c1. The KO mice were found to die 
perinatally, while those that survived after birth exhibited a deviation from the 
expected Mendelian ratio (3:6:1 for WT:HET:KO) but were recovered at 
embryonic times at the expected Mendelian ratio of (1:2:1 for WT:HET:KO). 
Interestingly, the surviving KO mice exhibited two PCD-like phenotypes of 
hydrocephalus and situs inversus. 59% of the mutant mice display situs inversus 
totalis, 17% show situs ambiguous while 24% are situs solitus. The laterality 
defects are known to result from the defects in the structure or function of motile 
nodal monocilia especially due to the loss of the extra-embryonic nodal flow 
proposed to carry morphogens responsible for the break of left-right asymmetry 
patterning. When the E7.5 embryonic mouse node of the Dyx1c1 WT and KO 
mouse was examined, we found that monocilia were present on the surface of 
the epithelial cells of the node in both the conditions; however the KO displayed a 
deposition of vesicle-like structures on the nodal surface indicative of a faulty 
nodal flow and abnormal ciliary function. 
The KO mice also developed severe hydrocephalus by P16 as evident from the 
thinning of the cortex and enlarged ventricles; these animals die by P21. 
Hydrocephalus could develop due to one or many of the following causes: i) 
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absence of cilia on the ependymal cells of the brain, ii) cilia are present but they 
are immotile, iii) abnormal production of the CSF, and iv) aqueductal stenosis. In 
order to understand the cause of hydrocephalus in the KO mice, we investigated 
whether the cilia were present on the ependymal cells of the ventricles and found 
by immunofluorescence analysis that tufts of cilia were present on the KO 
ependymal cells. However, live cell imaging and Indian ink assays showed that 
the KO ependymal cilia were non-motile. This phenotype of immotile cilia was 
consistent with the cilia of the tracheal epithelial cells of the KO, where we found 
an accumulation of mucus or debris on the surface of the cilia.  
Motile cilia defects are observed most commonly due to the defects in the ciliary 
ultrastructure components such as the outer and inner dynein arms, radial 
spokes or nexin links76. Transmission electron microscopy performed on the KO 
ependymal and tracheal cilia revealed an absence of both the outer and inner 
dynein arms that are known to be critical for ciliary motility.  
In summary, we show that the Dyx1c1 knockout mice exhibit PCD-like 
phenotypes, which resulted in axonemal defects of the dynein arms and ciliary 
dysmotility. The association between Dyx1c1 and PCD-like phenotypes was also 
recently reported in zebrafish, thus confirming the importance of Dyx1c1 in cilia 
structure and function133,136,137. Further studies are required to characterize the 
localization of the protein in ciliated cells in order to understand its role in ciliary 
motility. Also, identification of the interactor partners of Dyx1c1 would shed light 
on the functional pathway. Mutations in genes that are either axonemal dynein 
subunits of the ODA or IDA have been previously identified that cause PCD in 
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humans. Additionally, mutations in genes that are known to preassemble the 
outer and inner dynein arms in the cytoplasm, like DNAAF1, DNAAF2, and 
DNAAF3, or their transport to the basal bodies, similar to ODA16 have also been 
defined that are known to cause PCD102,104,138,139. Thus, Dyx1c1 can be added to 
the rapidly growing list of genes that when mutated cause PCD. Our data now 
suggest that Dyx1c1 is a novel dynein axonemal assembly factor Dnaaf4. 
 
2.5 Methods 
2.5.1 Gene targeting and genotyping of Dyx1c1Δ/Δ mice. 
 
Mice carrying the loxP– exon 2–4–loxP conditional allele of Dyx1c1 (Dyx1c1flox2–
4) were generated by the University of Connecticut Health Center Gene Targeting 
and Transgenic Facility. Embryonic stem cells harboring a loxP-flanked allele of 
exons 2–4 of Dyx1c1 were produced by electroporating mouse embryonic stem 
(ES) cells (129S6) with a targeting construct designed to replace exons 2–4 and 
flanking intronic sequence through homologous recombination. We screened 96 
ES cell clones by PCR for correctly targeted colonies. A single positive colony 
was expanded and used for embryo reaggregation to produce five chimeric mice. 
Three of these mice were shown to transmit the targeted allele through the germ 
line to offspring in a cross with C57BL/6J mice. The PGK-Neo cassette in the 
targeting construct was then removed by crossing these mice with 
129S4/SvJaeSor-Gt(ROSA)26Sortm1(FLP1)Dym/J mice (The Jackson Laboratory). 
These offspring were used to generate a colony of Dyx1c1flox2–4/flox2–4 mice. To 
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generate Dyx1c1del2–4/del2–4 (Dyx1c1Δ/Δ) mice with a deletion of exons 2–4, we 
crossed Dyx1c1flox2–4/flox2–4 mice with hypoxanthine-guanine 
phosphoribosyltransferase (Hprt)-cre mice, C57B6/6-Hprttm1(cre)Mnn/J (University 
of Connecticut Health Center). Genotyping was subsequently performed by PCR 
using two pairs of primers (Fig. 1a and Supplementary Table 4). Animal 
procedures were performed under protocols approved by the Institutional Animal 
Care and Use Committee of the University of Connecticut and conform to US 
NIH guidelines. 
 
2.5.2 Immunohistochemistry of mouse tissue. 
 
Mice were perfused transcardially with 0.9% saline followed by 4% 
paraformaldehyde (Electron Microscopy Science) in 1× PBS. Brains were 
removed, fixed overnight in the same fixative at 4 °C and washed in 1× PBS 
three times for 40 min the next day before cutting into 50-µm sections with a 
vibratome (VT-1000S, Leica). Nuclei were counterstained with Hoechst 33342 (2 
µg/ml in PBS; Sigma). Stained sections were washed for 10 min in PBS, 
coverslips were applied using Prolong Gold Antifade (Invitrogen), and images 
were acquired on a Carl Zeiss Axiovert 200M inverted microscope with an 
ApoTome attachment and Axiovision 4.6 software (Carl Zeiss). Whole mounts of 
the entire lateral wall of the lateral ventricles were prepared as described 
previously48, fixed overnight in 4% paraformaldehyde in PBS at 4 °C and washed 
in 1× PBS three times for 40 min the next day. They were then permeabilized 
with 0.1% Triton X-100 (Sigma) in PBS for 10 min, blocked in 10% goat serum 
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(Invitrogen) in PBS and 0.1% Triton X-100 for 1 h, and incubated with the 
following primary antibodies: mouse antibody to acetylated tubulin (1:500 dilution; 
Sigma, T6793), rabbit antibody to β-catenin (1:100 dilution; Cell Signaling 
Technology, 9562) and mouse antibody to γ-tubulin (1:500 dilution; Sigma, 
T6557). After washing three times in PBS, tissues were incubated with 
appropriate Alexa Fluor dye–conjugated secondary antibodies (Goat Anti-Rabbit 
488 (A11008), Goat Anti-Mouse 488 (A11001), Goat Anti-Rabbit 568 (A11011) 
and Goat Anti-Mouse 568 (A11031), Invitrogen) at a dilution of 1:400 for 1 h. 
Tissues were washed in PBS and incubated for 5 min in 2 µg/ml Hoechst 33342 
(Sigma) for counterstaining of nuclei. Secondary antibodies alone were used as a 
control. Whole mounts were placed onto depressed glass slides, and cover slips 
with CoverWell imaging chambers (Grace Bio-Labs) were applied. Samples were 
imaged either on a Carl Zeiss Axiovert 200M inverted microscope with an 
ApoTome attachment and Axiovision 4.6 software (Carl Zeiss) or on a Leica TCS 
SP2 confocal laser scanning microscope. 
2.5.3 Transmission Electron Microscopy (TEM) 
 
To collect brains, mice (12 d old) were perfused transcardially with 0.9% saline 
followed by 2% paraformaldehyde/2.5% glutaraldehyde in 0.1 mM phosphate 
buffer. Brain samples were further fixed by immersion overnight in 2% 
paraformaldehyde/2.5% glutaraldehyde in 0.1 mM phosphate buffer and were 
washed in phosphate buffer three times for 40 min per wash. Sections were 
postfixed with 2% OsO4 in 0.1 mM phosphate buffer for 1.5 h and were 
dehydrated through a graded ethanol series. After dehydration, tissues were 
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washed twice in acetone and embedded in epoxy resin in capped inverted Beem 
capsules. Thin sections were cut with a diamond knife, placed onto Formvar-
coated slot grids and heavy metal stained with uranyl acetate and lead citrate. 
Trachea tissues were directly dissected without perfusion and were fixed by 
immersion overnight in 2% paraformaldehyde/2.5% glutaraldehyde in 0.12 mM 
phosphate buffer. They were washed in phosphate buffer three times (60 min in 
total), postfixed in 1% OsO4 and 0.8% potassium ferricyanide in 0.12 M 
phosphate buffer for 1 h, dehydrated through a graded ethanol series, rinsed 
twice in acetone and embedded in epoxy resin. Thin sections were cut with a 
diamond knife, placed on copper grids and heavy metal stained with ethanolic 
uranyl acetate and Sato's lead citrate. Electron micrographs were captured using 
an FEI Tecnai 12 Biotwin TEM equipped with a side-mounted AMT XR-40 CCD 
camera. 
 
2.5.4 Scanning electron microscopy 
 
Wild-type and mutant mouse embryos (E7.5) were collected and fixed in 1.5% 
paraformaldehyde/1.5% glutaraldehyde in 0.10 M sodium cacodylate containing 
0.05 M NaCl overnight at 4 °C. Samples were postfixed with 2% OsO4 in the 
same buffer overnight and were dehydrated using a graded ethanol series. 
Specimens were dried in a Polaron E3000 Critical-Point Dryer and mounted onto 
aluminum specimen mounts (Ted Pella) using carbon tape and silver paint 
(Ernest F. Fullam). Each mount was sputter coated with gold palladium (60% 
gold, 40% palladium) using a Polaron E5100 Sputter Coater. Samples were 
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examined and photographed using a LEO DSM982 field emission scanning 
electron microscope. 
2.5.5 Protein blots of brain, lung and trachea lysates 
 
Wild-type and mutant mouse brains and lungs were collected and lysed in RIPA 
Buffer (Sigma) supplemented with 1× Protease Inhibitor Cocktail (Sigma). For 
tracheal and lung preparation, tissues were dissected and carefully separated 
from the surrounding tissues. Samples were homogenized using a tissue 
homogenizer and cleared by centrifugation at 10,000g for 10 min. Proteins were 
separated on 10% SDS-PAGE minigels and then transferred to Immobilon 
(Millipore) membrane for protein blotting. For detecting DYX1C1 protein, the 
antibody to N-terminal DYX1C1 (Sigma, SAB4200128) was used at a dilution of 
1:200; antibody to GAPDH (Sigma, G8795) was used at a 1:1,500 dilution as a 
loading control. LI-COR Odyssey infrared secondary antibodies (goat antibody to 
mouse 680 (926-32220), goat antibody to mouse 800 (926-32210) goat antibody 
to mouse 680 (926-32221) and goat antibody to mouse 800 (926-32211)) were 
used at dilutions of 1:10,000. All blots were imaged and analyzed using a LI-COR 
Odyssey Scanner and Software. 
2.5.6 Videomicroscopy of ependymal flow and cilia in mice 
 
P6–P10 wild-type and mutant mice were deeply anesthetized with isoflurane and 
were then decapitated. Brains were rapidly removed and immersed in ice-cold 
oxygenated (95% O2 and 5% CO2) dissection buffer containing 83 mM NaCl, 2.5 
mM KCl, 1 mM NaH2PO4, 26.2 mM NaHCO3, 22 mM glucose, 72 mM sucrose, 
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0.5 mM CaCl2 and 3.3 mM MgCl2. The lateral wall of the lateral ventricle was 
dissected using a fine scalpel and forceps and was immediately observed in a 
chamber containing buffer at 37 °C. For visualization of flow, a small amount of 
India ink was placed on the surface of the lateral wall of the dissected ventricle. 
Movement of India ink was observed and recorded using infrared DIC 
microscopy (E600FN, Nikon) and a CCD camera (QICAM, QImaging, 120 frames 
per second (fps)). For direct observation of cilia movement, mouse brains were 
harvested as above, and coronal slices (400 µm) were cut using a vibratome 
(Leica, VT1200S). Slices from the third ventricle through the fourth ventricle were 
visualized using infrared DIC and a CCD camera. Images were analyzed with 
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3. CELLULAR LOCALIZATION OF DYX1C1 AND 
IDENTIFICATION OF ITS INTERACTION PARTNERS 
 
3.1 Abstract 
Dyx1c1 knockout mice display Primary Ciliary Dyskinesia (PCD) like phenotypes 
that include Situs Inversus and early onset hydrocephaly. Live cell imaging and 
an Indian ink flow assay indicated a lack of ciliary motility in the knockout mice 
compared to the wildtype. Ultrastructural and immunofluorescence analyses of 
Dyx1c1 mutant motile cilia in mice showed disruptions of outer and inner dynein 
arms (ODAs and IDAs, respectively). Previous protein interaction studies suggest 
possible roles for Dyx1c1 in chaperonin function (Chen et al 2009). In this study, 
we determine the interaction partners of Dyx1c1 to understand its role in ciliary 
motility. Immunoprecipitation and mass spectrometric analysis experiments 
reveal that the Dyx1c1 interactome is enriched for proteins of the categories 
molecular chaperones as well as cytoskeletal proteins. We find by 
immunoprecipitation experiments that Dyx1c1 interacts with heat shock proteins 
and T-complex chaperones. Dyx1c1 also interacts with Septin2, a protein of the 
ciliary transition zone with implicated function in ciliary protein trafficking. 
Assessment of localization of Dyx1c1 identified that Dyx1c1 localizes to the 
cytoplasm of nasal respiratory epithelial cells. We performed tracheal deciliation 
to obtain axonemal and cilia-stripped tracheal fractions and further tested the 
lysates for the presence of the ODA and IDA subunits. Interestingly, we found 
that there was a reduction in the IDA subunit Dnali1 as well as ODA intermediate 
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chains Dnai1, Dnai2 and light chains Dnal4 and Dnal1. Our observations thus 
lead to the hypothesis that Dyx1c1 plays a role in cytoplasmic assembly of ciliary 
dyneins and/or their transport to the ciliary transition zone.  
3.2 Introduction 
 
Dyx1c1, a 420 amino acid protein, was first identified as a candidate dyslexia 
susceptibility gene112. The protein is ubiquitously expressed in brain, amongst 
other tissues, and is found to localize to the in the nuclei and cytoplasm of 
neurons and glia in human neocortex. The protein domains of DYX1C1 include 
an N-terminal p23 and three C-terminal TPR domains. This combination of a p23 
and TPR domains is shared with Sugtl, a protein known to play a role in 
kinetochore assembly in yeast, suggesting a potential role in cell division or cell 
dynamics. DYX1C1, when over-expressed in cell lines, can interact with Hsp70, 
Hsp90 and an E-3 ubiquitin ligase, Chip, suggesting that DYX1C1 may also be 
involved in the degradation of unfolded proteins127,128. At its C-terminal, there are 
three tetratricopeptide domains (TPR) which function in protein-protein 
interactions. 
 
To elucidate the biological functions of Dyx1c1, exons 2-4 of Dyx1c1 were 
deleted in mice. No detectable Dyx1c1 protein expression was observed by in all 
tissues tested, including brain and lung. The knockout mouse exhibited PCD-like 
phenotypes of situs inversus and hydrocephalus; both characterized by defects 
of motile cilia. Light microscopy revealed the presence of cilia on the surface of 
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the brain ependymal cells; however these cilia were completely immotile in the 
KO as evidenced by the videomicroscopy analysis. Analysis into the 
ultrastructural defects of the cilia exhibited an absence of both the inner and 
outer dynein arms (IDA and ODA) that are responsible for the motility of the 
cilia140.     
 
Nonstructural cilia-associated proteins have been found to be mutated in PCD 
individuals and result in the absence of outer and inner dynein arms. These 
mutations involve proteins that are considered to function in cilia assembly or 
“preassembly” pathways. Identification of the involvement of these proteins has 
prompted research into the mechanisms of cilia biogenesis especially into the 
following processes: intra-axonemal transport, transfer into the cilium, and 
cytoplasmic preassembly56,141. The first PCD-associated preassembly protein 
found was DNAAF2, the loss of which lead to complete absence of outer and 
inner dynein arms. Localized within the apical region of the cell cytoplasm, 
DNAAF2 interacts with Hsp90 and DNAI2 to facilitate assembly or dynein 
complex transport into the cilia138. Mutations in the proteins DNAAF1 and 
DNAAF3 caused outer dynein arm defects in patients with PCD102,104. Evidence 
for assembly roles of these proteins is substantiated in mutant cells where 
components of the dynein arm complex were found to either accumulate or 
deplete from the mutant cytoplasm leading to a failure in their transport into the 
ciliary axoneme. Mutations in LRRC6, a protein that is found in the cytoplasm but 
colocalizes to the basal bodies, also lead to PCD142.  
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Identification of the localization of Dyx1c1 will help us understand which of the 
cilia biogenesis processes such as intra-axonemal transport, transfer into the 
cilium, or cytoplasmic preassembly it is involved in. Also the previously defined 
assembly factors function by interacting with the chaperones and the axonemal 
dynein subunits of the dynein arms themselves. It is hence required to identify 
the interaction partners of Dyx1c1 to detail its role in the ciliary motility. In this 
study, we perform immunofluorescence analysis to find that Dyx1c1 localizes to 
the apical cytoplasm of the ciliated cells. Furthermore, mass spectrometric 
analysis identified the interactome of Dyx1c1, wherein the chaperone category of 
proteins was enriched followed by the cytoskeletal proteins.  We confirmed the 
interaction of Dyx1c1 with the mass spectrometry (MS)-identified proteins like the 
heat shock proteins Hsp70 and Hsp90; CCTs and Septin 2. We found that the 
TPR domains of Dyx1c1 are necessary for mediating the interaction between 
Hsp70 and CCTs; whereas the Hsp90 interaction was mediated via the p23 
domain. We thus hypothesize that Dyx1c1 acts as a co-chaperone assisting in 
the cytoplasmic preassembly of the axonemal dyneins and their subsequent 
transport to the base of the cilium at the transition zone.  
 
3.3 Results  
3.3.1 Sub-cellular localization of Dyx1c1  
 
To characterize the functional role of Dyx1c1 in ciliary motility, it is necessary to 
analyze the expression of Dyx1c1 in the ciliated tissues. Also, the phenotypes 
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described above as well as previously reported interactions between 
exogenously expressed DYX1C1 protein and molecular chaperones suggested 
to us that DYX1C1 might function as a newly identified axonemal dynein 
assembly factor. We found by immunofluorescence that mouse Dyx1c1 protein 
was located in the cytoplasm of respiratory epithelia (Fig. 3-1).  
 
In order to confirm the cytoplasmic localization of Dyx1c1; we developed a 
protocol for separation of the ciliary axonemes from the trachea of Dyx1c1 
 
Figure 3-1: Dyx1c1 localizes to the cytoplasm of ciliated epithelial cells. 
Immunofluorescence analyses of mouse nasal epithelial cells stained for 
acetylated tubulin (green) and Dyx1c1 (red). In Dyx1c1+/+ mice, Dyx1c1 localizes 
to the cytoplasm of the epithelial cells and partly to the basal bodies but is absent 
in the cilia. In the mutant, Dyx1c1 is absent from the cytoplasma. Nuclei were 
stained with Hoechst 33342 (blue). 
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wildtype and knockout mouse. After harvesting tracheas in cold PBS, they were 
then incubated in chilled buffer containing 20mM calcium that induces deciliation 
of the trachea. The mechanism underlying Ca++ induced deciliation involves a 
calcium-binding protein centrin, which is a part of the stellate fibers of the 
transition zone, contraction of which causes the severing of microtubules at the 
transition zone. The region of the detached cilia seals over, minimizing the 
protein leakage out of the cell body87. The tracheas were then separated from the 
buffer containing the ciliary axonemes, and incubated in lysis buffer to obtain the 
cytoplasmic fraction that contains the trachea stripped of the axonemes. The 
axonemal fraction was further spun down at low speed to pellet any cellular 
debris. The pellet is discarded and the axoneme-containing buffer is further spun 
down at high speed for about 30 min to pellet the axonemes, which are then 
incubated in lysis buffer to get the axonemal lysate.  
 




Figure 3-2: Deciliation of Dyx1c1 wildtype and knockout trachea (a) Deciliation 
workflow. (b) Immunofluorescence analysis of the axonemal fraction of the wildtype 
(left panel) and knockout (right panel) using anti-acetylated tubulin (cilia, red) and 
Hoechst (nuclear stain, blue). (c) Coomassie stained gel showing the axonemal and 
deciliated tracheal lysates of the wildtype and knockout. (d) Western blot probed with 
acetylated tubulin, Gapdh (control) and Dyx1c1. Axo: axonemal fraction; Cyto: 
cytoplasmic fraction. 
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We thus obtain two fractions after the deciliation workflow (Fig. 3-2a): i) 
cytoplasmic fraction containing the trachea stripped off the ciliary axoneme and 
ii) axonemal fraction consisting of the ciliary axoneme. The separated axonemes 
were analyzed for their purity by using immunofluorescence analysis (Fig. 3-2b). 
It was observed that there was little to no contamination of the cells in the 
axonemal preparation. The deciliation was confirmed by Coomassie staining (Fig. 
3-2c) and western blot (Fig. 3-2d). Western blot was performed using lysates of 
the whole trachea, cytoplasmic extract, and axonemal extract of both the Dyx1c1 
wildtype and knockout, and the blot was stained with acetylated tubulin (a marker 
for cilia), Gapdh, as well as Dyx1c1 (Fig. 3-2d). We found that the wildtype and 
knockout axonemal fraction expressed acetylated tubulin with little contamination 
of the Gapdh-containing cytoplasmic fraction and vice-versa; whereas the whole 
trachea from the Dyx1c1 wildtype and knockout mice showed the presence of 
both Gapdh and acetylated tubulin. We also showed that Dyx1c1 is present in 
the cytoplasmic fraction of the wildtype trachea and absent from the wildtype 
axonemal and knockout cytoplasmic as well as axonemal fraction. Gapdh was 
used as the marker for the cytoplasmic fraction (Fig. 3-2d).  
3.3.2 Identification of the interaction partners of Dyx1c1 
 
To categorize the molecular function of Dyx1c1 more completely in respiratory 
tissue, we defined the protein interactome of Dyx1c1 in mouse trachea by co-
immunoprecipitation and tandem mass spectrometry. We prepared input extracts 
for co-immunoprecipitation from the tracheal tissue of either wildtype or mutant 
mice and found that these appeared similar in protein composition, as evaluated 
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by Coomassie staining after SDS-PAGE. After co-immunoprecipitation with 
antibodies to Dyx1c1, Coomassie-stained protein bands were apparent in 
preparations from wild-type extracts but not in those generated from mutant 
extracts. We cut 14 matched pairs of gel pieces covering the range from 
approximately 20 to 200 kDa, with many pieces containing multiple bands, from 
wild-type and mutant co-immunoprecipitations and subjected them to tryptic 
digestion and tandem mass spectrometry analysis for protein identification. In all, 
we identified 702 proteins in immunoprecipitates from wild-type trachea and 29 
proteins in gel slices from the immunoprecipitates from trachea expressing 
mutant protein (Supplementary Table 1).  
To determine whether the identified Dyx1c1 protein interactome was enriched for 
particular molecular or biological functions, we used the Database for Annotation, 
Visualization and Integrated Discovery (DAVID) to determine the presence of 
enriched Panther Gene Ontology terms in the Dyx1c1 interactome and proteins 
identified in the knockout control. Using a mouse lung proteome as background, 
we found several molecular functional categories enriched in the Dyx1c1 
interactome, and several of these were in categories containing molecular 
chaperones (MF00077: chaperone, P < 0.001; MF00091: cytoskeletal proteins, P 
< 0.001; BP00062: protein folding, P < 0.01; BP00072: protein complex assembly, 
P < 0.05; and MF00078: chaperonin, P = 0.05; Table 3-1). All four of these 
chaperone-containing categories were not significantly enriched in the protein set 
identified in the immunoprecipitates with mutant protein (Table 3-1).  
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The DYX1C1 interactome contained a total of 28 proteins in the chaperone or 
chaperonin category, including 6 of 8 subunits in the T-complex chaperonin 
Table 3-1: Complete list of PANTHER Gene Ontology enrichment terms from Dyx1c1 
wild-type subtracted by knockout control with a lung proteome as a background. 
Thick horizontal line separates statistically significant terms (p < 0.05) from non-
statistically significant terms (p > 0.05). 
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complex and multiple heat-shock proteins. In addition to the chaperones, another 
interesting family of proteins, Septins, was identified as a part of the Dyx1c1 
interactome.  
Septins are evolutionarily conserved family of small GTPases that form hetero-
oligomers, which assemble into filaments, rings and spirals.  In mammals, 
Septins have been linked to scaffolding functions with the cytoskeleton especially 
through their interactions with actins. Sept2 interacts with MAP4 that positively 
regulates the polymerization/stability of cytoplasmic microtubules. Map4 directly 
binds and bundles microtubules in turn regulates the Septin-microtubule 
interactions. Septins organize lateral membrane diffusion barriers between the 
ciliary compartment and the surrounding plasma membrane in the sperm 
flagellum143, primary cilium3 and motile cilia. The transition zone includes the 
region where the basal body is docked onto the cellular membrane, and extends 
distally to link microtubule doublets to the ciliary membrane by Y-shaped 
molecular links. Septins form a ring-shaped structure at the base of cilia. Sept2 is 
also required for ciliogenesis, thereby linking septins to ciliary function and 
morphogenesis3,143. The mass spectrometric analysis performed on the wildtype 
immunoprecipitates identified Septin2 and Septin 7 as a part of the Dyx1c1 
interactome.  
Cytoplasmic dyneins are thought to be involved in linking dynein to cargos and to 
adapter proteins thus regulating dynein function. Cytoplasmic dynein also acts as 
a motor for the intracellular retrograde motility of vesicles and organelles along 
microtubules. The intermediate chains of the cytoplasmic dyneins are known to 
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mediate the binding of dynein to dynactin via the 150 kDa component of DCNT1; 
thus functioning in membrane-transport. Our MS/MS screen identified the 
intermediate chain of the cytoplasmic dyneins, Dync1i1.  
We confirmed the interaction of Dyx1c1 with Hsp70, Hsp90, Cct3, Cct4, Cct5, 
Cct8, Sept2 and Dync1i1 by co-immunoprecipitation and western blot analysis 
(Fig. 3-3). 
  
3.3.3 Interaction of Dyx1c1 with the interaction partners in HEK cells 
 
Dyx1c1 protein contains N-terminal heat shock protein family domain and C-
terminal TPR domains that are known to mediate protein-protein interactions. 
TPR-containing proteins have been previously studied for their roles in molecular 
  
Figure 3-3: Identification of interaction partners of Dyx1c1. Co-
immunoprecipitations and western blot analyses show the interaction of Dyx1c1 with 
the chaperones Cct3, Cct4, Cct5, Cct8, Hsp70 and Hsp90. Dyx1c1 also interacts with 
cytoplasmic dynein 1 intermediate chain 1 (Dync1i1) protein as well as Septin-2 
(Sept2).  
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protein complexes, anaphase promoting complexes, transcription repression 
complexes, and the organization of protein import complexes128.  
3.3.3.1 Interaction of Dyx1c1 with heat shock proteins Hsp70 and Hsp90 
 
Dyx1c1 is known as a co-chaperone due to its previously identified interactions 
with the heat shock proteins Hsp70 and Hsp90. It is known that Dyx1c1 interacts 
with Hsp70 via its TPR domains while the p23 is sufficient for the interaction of 
Hsp90 and Dyx1c1. Our MS/MS data identified chaperones Hsp70 and Hsp90 in 
the interactome of Dyx1c1; we confirmed that Dyx1c1 interacts with both Hsp70 
and Hsp90 (Fig 3-3). We decided to investigate this interaction in a heterologous 
expression system. We transfected HEK cells with the full-length, N-terminal 
truncation and C-terminal truncation constructs of Dyx1c1 all fused to GFP; and 
decided to investigate the interaction of full-length and truncation constructs of 
Dyx1c1 with endogenous Hsp70 or Hsp90 (Fig. 3-4). We found that Dyx1c1 full-
length protein co-immunoprecipitated with both Hsp70 and Hsp90. The TPR 
domains mediated the interaction of Hsp70 while the p23 domain aided that of 
Hsp90.  
3.3.3.2 Interaction of Dyx1c1 with the T-complex chaperones 
 
Chaperonins are large double-ring complexes of ~800−900 kDa that function by 
enclosing substrate proteins up to ~60 kDa for folding. Group I chaperonins (also 
known as HSP60s in eukaryotes and GroEL in bacteria) have seven-membered 
rings in bacteria, mitochondria and chloroplasts, and functionally cooperate with 
HSP10 proteins (GroES in bacteria), which form the lid of the folding cage. The 
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most complex group II chaperonin is however the eukaryotic cytosolic chaperonin 
containing TCP1 [CCT, also termed TRiC (TCP1 ring complex)], which is 
composed of eight different subunits (CCTα, β, γ, δ, ɛ, ζ, η and θ in mammals, 
CCT1–8 in yeast) organized in a unique intra- and inter-ring arrangement. They 
are independent of HSP10 factors144-147. They are known to be involved in the 
quality control of cytoskeletal proteins and also tubulin biogenesis.  
Our MS/MS screen identified four of the eight CCTs Cct3, Cct4, Cct5 and Cct8. 
We confirmed by co-immunoprecipitation and protein blot analysis the 
interactions of these four six chaperones with DYX1C1 (Fig. 3-3). We also further 
confirmed the interaction of Dyx1c1 with these Ccts heterologously. We used 
HEK cell lysates transfected with full-length Dyx1c1, N-terminal and C-terminal 
truncation constructs of Dyx1c1 to pull down Dyx1c1 protein; and further blotted 
with the Cct antibodies to test for the interaction of Dyx1c1 with the Ccts. We 
found that all the Ccts interacted with Dyx1c1 via the TPR domains (Fig. 3-4).  
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Figure 3-4: Dyx1c1 interacts with the chaperones. (a) Co-immunoprecipitation and 
western blot analysis shows that transfected Dyx1c1-GFP interacts with endogenous 
HSp70 and Hsp90; Dyx1c1-∆p23-GFP interacts with Hsp70; while Dyx1c1-∆TPR-
GFP interacts with Hsp90. (b) Co-immunoprecipitation and western blot analysis 
shows that transfected Dyx1c1-GFP interacts with endogenous Cct3, Cct5 and Cct8. 
Dyx1c1-∆p23-GFP interacts with the CCTs. GFP condition acts as a control. 
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3.3.4 Cytoplasmic abundance of dynein subunits of IDA and ODA 
 
Previous studies have shown that Chlamydomonas can disassemble and 
subsequently reassemble their flagella once each cell cycle while maintaining a 
cytoplasmic pool of flagellar dynein subunits enough to assemble half-length of 
the flagella in the absence of any protein synthesis148,149. The dynein assembly 
mutations could either prevent the dynein complex from preassembling in the 
cytoplasm or block the IFT-mediated transport of the assembled complex into the 
flagella. In order to understand the Dyx1c1 aided assembly process it is hence 
important to examine the cytoplasmic pool of axonemal proteins by biochemical 
analysis. Loss of function of the previously studied assembly factors Ktu and 
Lrrc50 reduces the abundance of some ODA HC subunits while increasing the 
abundance of the ODA IC subunits in the cytoplasm. In the Lrrc6 mutant 
cytoplasm, the ODA HCs are retained at wildtype levels while the IC subunit 
Dnai2 is hyperabundant, which suggests that the Lrrc6 mutation has an effect on 
the assembly of heavy chains with intermediate chains56,102,150.  
In order to assess the cytoplasmic abundance of the dynein subunits in the 
cytoplasm of the Dyx1c1 mutant, we performed deciliation of the trachea 
obtained from wildtype and knockout Dyx1c1 mice. We confirmed the 
cytoplasmic localization of Dyx1c1 in the wildtype extracts and the deciliation was 
confirmed by the presence of acetylated tubulin only in the axonemal fraction 
with little to no expression in the cytoplasmic extract using Gapdh as the control 
for the cytoplasmic fraction. Having confirmed the deciliation, we then decided to 
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investigate the abundance of the dynein subunits in the cytoplasmic fraction 
obtained from the WT and KO trachea.  
 
Western blots of cytoplasmic extracts showed that in the Dyx1c1 knockout 
cytoplasm, the abundance of ODA intermediate chains Dnai1 (Fig. 3-5a) and 
Dnai2 (Fig. 3-5b) was reduced. Compared to the wildtype cytoplasm, the levels 
of Dnai1 were decreased by about half whereas the levels of Dnai2 were 
Figure 3-5: Outer dynein arm intermediate and light chain subunits are reduced 
in the Dyx1c1 knockout tracheal cytoplasm. Western blot analysis (top panel) and 
quantification (bottom) of the dynein subunits shows reduced cytoplasmic abundance 
of Dnai1 (red) (a), Dnai2 (red) (b), Dnal1 (red) (c), and Dnal4 (red) (d). Gapdh is used 
as a loading control and for normalization. Student’s T-test, P-value<0.01(*); P-value 
<0.05 (**). 
	  	   77 
reduced by 99% in the knockout cytoplasm. In addition to the intermediate chains, 
the abundance of some of the light chains was altered as well in the knockout 
cytoplasm. There was a seven-fold decrease in the abundance of the light chain 
Dnal1 (Fig. 3-5c), while a 98% reduction in abundance of Dnal4 (Fig. 3-5d) in the 
knockout cytoplasm when compared to the wildtype cytoplasm. Thus, the Dyx1c1 
mutation suggests a defect in assembling the intermediate chains and/or light 
chains of the ODA complex or the maintenance of these axonemal dyneins.  
Since ultrastructural studies of the cilia from the Dyx1c1 knockout mice show the 
absence of both the inner and outer dynein arms as well as the 
immunocytochemistry indicates the lack of expression of the IDA subunit Dnali1 
from the mutant ciliary axoneme, we looked at the abundance of the IDA light 
intermediate chain subunit Dnali1 (Fig. 3-6). We found that the cytoplasmic 
abundance of the light intermediate chain Dnali1 was also reduced to about 4% 




Figure 3-6: Inner dynein arm light intermediate chain Dnali1 is reduced in the 
Dyx1c1 knockout tracheal cytoplasm. Western blot analysis (left panel) and 
quantification (right panel) of Dnali1 shows reduced cytoplasmic abundance. Gapdh 
is used as a loading control and for normalization. Student’s T-test, P-value<0.01(*). 
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The results suggest that, in the cytoplasm of the Dyx1c1 knockout tracheal cells, 
the ODA intermediate chain subunits Dnai1 and Dnai2; the ODA light chain 
subunits Dnal1 and Dnal4; as well as the IDA light intermediate chain subunit 
Dnali1 might be undergoing rapid degradation due to the lack of their 
incorporation into the ODA or IDA complex. Thus we propose that Dyx1c1 is 
indeed required for the cytoplasmic preassembly of the ciliary dyneins and the 
absence of which leads to protein degradation due to the defect in the assembly 
process.  
3.4 Discussion  
 
To identify the function of Dyx1c1 in ciliary motility, it was important to first 
characterize the subcellular localization of the protein. Since the loss of Dyx1c1 
is known to cause an absence of ODA and IDA in the ciliary axoneme, it could 
localize to the ciliary axoneme and play in role in attachment of the ODA and IDA 
to the microtubules; or Dyx1c1 could be a cytoplasmic protein functioning in the 
assembly of the ODA and/or IDA or subsequent transport of the assembled 
motor complexes to the base of the cilia.  
When immunofluorescence analysis was performed on the acutely dissociated 
nasal respiratory cells, we identified a cytoplasmic localization for Dyx1c1. Three 
other proteins, termed as assembly factors of axonemal dyneins, DNAAF1, 
DNAAF2 and DNAAF3 are identified that localize to the cytoplasm and are 
involved in the pre-assembly of the axonemal dyneins before their transport into 
the ciliary axoneme. Due to the cytoplasmic localization of Dyx1c1, we proposed 
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that Dyx1c1 probably functions like the assembly factors mentioned above.  
Dyx1c1 has identified as a co-chaperone due to its interaction with the heat 
shock proteins Hsp70 and Hsp90. In addition, Dyx1c1 is also implicated in 
protein quality control due to its interaction with the E3 ubiquitin ligase, CHIP. To 
characterize the function of Dyx1c1 in greater detail, we next identified the 
interactome of Dyx1c1 by immunoprecipitation and mass spectrometric analysis. 
We identified previously known interactors like the heat shock proteins Hsp70 
and Hsp90; in addition to these, we also found a group of chaperonins (T-
complex chaperones) that interact with Dyx1c1. We further identified that the 
TPR domains of Dyx1c1 are critical for the interaction of the Hsp70 and CCTs 
with Dyx1c1, while the p23 domain of Dyx1c1 mediates the interaction with 
Hsp90. These results validate the function of Dyx1c1 in chaperone-mediated 
processes or especially as a co-chaperone. In addition, Dyx1c1 interactome also 
consisted of proteins that are a part of the proteasomal degradation pathway. 
Due to these findings, we speculate that Dyx1c1 might be involved in the quality 
control or stability of the unfolded protein complexes. It might however also be 
involved in the degradation of the misfolded protein complexes due to its 
association with the proteasomal pathway subunits as well as its previously 
known interaction with CHIP.  
Interestingly, the newly identified interaction partner of Dyx1c1, Sept2, hints at a 
role of Dyx1c1 at the transition zone of the cilium. We have hypothesized that 
Dyx1c1 is involved in the cytoplasmic preassembly of ciliary dyneins. Once these 
ciliary dyneins have assembled in the cytoplasm, they need to be transported to 
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the transition zone before entering the axoneme. Dyx1c1 might be responsible 
for the stability of the assembled dynein arm complexes and hence might be 
transporting this complex to the Sept2-containing transition zone, where the 
motor complex then gets docked onto the intraflagellar transport (IFT) complex.  
The cytoplasm of the ciliated epithelial cells generates a precursor ODA and IDA 
motor complex, hence investigation into the cytoplasmic abundance of the ODA 
and IDA dynein subunits will give us insights into the biochemical function of 
Dyx1c1. We performed deciliation of the trachea obtained from the WT and KO 
to assess the abundance of the ODA and IDA subunits in the deciliated tracheal 
lysates. Interestingly, we found that the ODA intermediate chain subunits Dnai1 
and Dnai2 were depleted from the KO cytoplasm; as were the ODA light chain 
subunits Dnal1 and Dnal4. The light intermediate chain subunit of the IDA 
complex, Dnali1, was also reduced in the KO cytoplasm compared to the control. 
These results suggest that Dyx1c1 is probably required for the proper folding of 
these subunits in the KO; in the absence of Dyx1c1, the subunits fold abnormally 
leading to their rapid degradation. Alternatively, the axonemal dynein subunits 
might be folded correctly, but due to the lack of Dyx1c1 their incorporation as an 
ODA or IDA is affected. Since the subunits are not assembled accurately, they 
might be degenerating at a faster rate in the KO than the WT. A third possibility is 
that Dyx1c1 plays a role in the transcriptional regulation of the axonemal dynein 
subunits and loss of Dyx1c1 affects the synthesis of the proteins.  
In summary, we hypothesize that Dyx1c1 plays a role in the cytoplasmic 
preassembly of the axonemal dyneins mediated by its interaction with the 
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chaperones. It might also assist in the stability of the individual dynein subunits or 
the assembled ODA/IDA complex. Due to the interaction of Dyx1c1 with Sept2, 
we also predict that Dyx1c1 is required for the transport of the assembled ODA 
or IDA complex to the transition zone, which is the checkpoint for the assembled 
motor complex to enter the axoneme. 
3.5 Materials and Methods 
3.5.1 Immunofluorescence of dissociated mouse nasal epithelial cells 
 
Nasal epithelial cells were harvested from mouse septa by acute dissociation on 
a 4-well slide in 1:1 PBS/HBSS. Slides were dried to let the cells adhere to the 
wells, and cells were immediately fixed with 4% paraformaldehyde for 2 min at 
room temperature. Cells were then washed twice with 1× PBS for 2 min for each 
wash. Blocking buffer (10% goat serum and 0.1% Triton X-100 in 1× PBS) was 
added for 15 min at room temperature. Slides were incubated with rabbit 
polyclonal antibody to DYX1C1 (Sigma, SAB4200128) at a 1:500 dilution and 
mouse monoclonal antibody to acetylated tubulin (Sigma, T7451) at a 1:1,000 
dilution in the same blocking buffer for 30 min at room temperature. After three 
washes with 1× PBS for 5 min each, slides were incubated with Alexa Fluor 488–
conjugated goat antibody to rabbit (Invitrogen, A11034; 1:5,000 dilution) and 
Alexa Fluor 568–conjugated goat antibody to mouse (Invitrogen, A11031; 
1:1,000 dilution) for 20 min at room temperature. Slides were washed twice with 
1× PBS for 5 min each, and nuclear stain Hoechst 33342 (Invitrogen, H3570) at a 
1:2,500 dilution was added for 15 min at room temperature. Slides were dried, 
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and cover slips were applied with Prolong Gold Antifade (Invitrogen, P36930). 
Cells were imaged on a Leica TCS Sp2 laser scanning microscope.  
3.5.2 Basic peptide identification by tandem mass spectrometry 
 
After separation by SDS-PAGE, proteins were stained with Coomassie dye. 
Fourteen gel pieces were excised from the gels that contained bands in the 
immunoprecipitates with wild-type Dyx1c1 or were adjacent to these bands in the 
lane containing immunoprecipitates with mutant Dyx1c1. Bands were in-gel 
digested with trypsin, and resulting peptides were analyzed using liquid 
chromatography tandem mass spectrometry on a Thermo Scientific LTQ-Orbitrap 
XL mass spectrometer equipped with Waters nanaoACQUITY ultra-high-
pressure liquid chromatographs (UPLCs) for peptide separation. The liquid 
chromatography tandem mass spectrometry data were searched with an in-
house Mascot algorithm for uninterpreted tandem mass spectrometry spectra 
after using the Mascot Distiller program to generate Mascot compatible files. 
Charge states of +2 and +3 were preferentially located with a signal-to-noise ratio 
of 1.2 or greater, and a peak list was generated for database searching. NCBInr, 
a mouse- specific database (in FASTA format), was used for searching.  
3.5.3 Tandem mass spectrometry and gene ontology enrichment analysis 
  
Raw tandem mass spectrometry peptide sequencing results for the wild-type and 
control analyses obtained from the Yale W.M. Keck Foundation Proteomics 
Resource were stringently filtered to ensure a low false positive protein 
identification rate. Specifically, proteins were considered identified only if they 
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contained two or more unique peptides with expectation values of <0.01. 
Resulting unique protein GI accession numbers for the wild-type and controls 
were separately used as inputs for the DAVID bioin- formatics resource with the 
mouse proteome selected as the background49,50. To detect enrichment in 
gene ontology terms associated with the input pro- teins, the PANTHER 
biological process and PANTHER molecular function annotations were selected, 
and functional annotation charts were generated. To further account for high-
abundance proteins commonly observed in tandem mass spectrometry analyses, 
a list of 1,000 mouse protein Swiss-Prot accession numbers was obtained from 
the Global Proteome Machine web site and was used as an alternate 
background in the DAVID gene ontology analysis of DYX1C1 interactors.  
3.5.4 Deciliation of the trachea 
 
The tracheas harvested from postnatal day 16 (P16) Dyx1c1 wildtype and 
knockout mice were washed with cold phosphate-buffered saline to remove 
mucus and cell debris. Animal procedures were performed under protocols 
approved by the Institutional Animal Care and Use Committee of the University of 
Connecticut and conform to US NIH guidelines. The dissected tracheas were 
transferred to a separate tube containing deciliation buffer containing 10mM Tris-
HCl (pH 7.5), 50mM NaCl, 20mM CaCl2, 1mM EDTA, 0.1% TritonX-100, 7mM 
betamercaptoethanol, and 1% volume of protease inhibitor mixture; incubated for 
10 min with intermittent mild vortexing. The supernatant was collected in a 
separate tube, and the procedure was repeated twice. The tracheas were then 
separated from the supernatant, the three washings were pooled, and after 
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pelleting cell debris at 800xg, the ciliary axonemes were collected by 
centrifugation at 20,000xg. Ciliary axonemal pellets were resuspended gently in 
30 mM Hepes (pH 7.3), 1 mM EGTA, 0.1 mM EDTA, 25 mM NaCl, 5 mM MgSO4, 
1 mM dithiothreitol, and 1% volume of protease inhibitor mixture (Sigma). Triton 
X-100 was added (0.5%) to the suspension, and the axonemes were incubated 
for 15 min on ice, followed by centrifugation. The lysates containing the 
axonemal fraction were then frozen at -80°C. The cilia-stripped-tracheas were 
incubated in RIPA buffer (Sigma) on ice for 20 min. Samples were homogenized 
using a tissue homogenizer and cleared by centrifugation at 10,000g for 10 min 
to obtain the protein lysate of the cytoplasmic fraction of the trachea. Protein 
concentrations were estimated using the BCA reagent (Pierce).  
3.5.5 Protein blots of whole trachea, cytoplasmic and axonemal lysates 
 
For whole tracheal preparation, tracheal tissues were dissected from wildtype 
and knockout mice, and carefully separated from the surrounding tissues. After 
incubation in RIPA Buffer supplemented with 1× Protease Inhibitor Cocktail 
(Sigma), samples were homogenized using a tissue homogenizer and cleared by 
centrifugation at 10,000g for 10 min. The cytoplasmic and axonemal fractions of 
the trachea were prepared as described above. Proteins were separated on 12% 
SDS- PAGE minigels and then transferred to Immobilon (Millipore) membrane for 
protein blotting. For detecting DYX1C1 protein, the antibody to N-terminal 
DYX1C1 (Sigma, SAB4200128) was used at a dilution of 1:200; antibody to 
acetylated tubulin (Sigma, T6793) was used at a dilution of 1:2000; and antibody 
to GAPDH (Sigma, G8795) was used at a 1:1,500 dilution as a loading control. 
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LI-COR Odyssey infrared secondary antibodies (goat antibody to mouse 680 
(926-32220), goat antibody to mouse 800 (926-32210), goat antibody to rabbit 
680 (926-32221) and goat antibody to rabbit 800 (926-32211)) were used at 
dilutions of 1:15,000. All blots were imaged and analyzed using a LI-COR 
Odyssey Scanner and Software.  
3.5.6 Cell culture and transfection 
 
Human embryonic kidney (HEK293T) cells were grown to confluence in DMEM 
supplemented with 10% FBS, 1% non-essential amino acid (NEAA) and 1% 
penicillin-streptomycin antibiotics (Invitrogen). Cultures were plated at a density 
of 106 cells on a 10-cm petridish. DNA (24 µg) was added to the petridish with 75 
µl of Lipofectamine 2000 reagent (Invitrogen) in OptiMEM-1. The transfection mix 
was added to cells in normal growth media and incubated for 48 h at 37 °C. To 
obtain the protein lysates from the cells, the normal growth media was removed 
and the cells were washed with PBS. The cells were then collected, centrifuged 
to pellet the cells and the pellet was incubated in RIPA buffer supplemented with 
1X Proteinase Inhibitor Cocktail for 20 min on ice. The lysates were then 
centrifuged at 2000xg to pellet the debris. Protein blots were also performed on 
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4. CHARACTERIZATION OF MUTANT DYX1C1 PROTEIN 
AND ITS INTERACTIONS  
4.1 Abstract 
Defects in motile cilia cause primary ciliary dyskinesia (PCD), characterized by 
chronic airway disease, infertility, and left-right laterality disturbances. Dyx1c1 
(DNAAF4) was identified as a candidate PCD gene, mutations in which resulted 
in loss of the outer and inner dynein arms. 12 biallelic PCD-causing mutations 
were identified in Dyx1c1, which were speculated to cause either protein 
degradation or a truncated protein product lacking the TPR domains of Dyx1c1. 
Interestingly, a novel missense mutation p.Leu19Glu was identified in a Druze 
cohort that coincidentally segregated with PCD. The patients suffer from the 
classical PCD symptoms and the patient cilia show an absence of inner dynein 
arms. Here, we show that the DYX1C1 protein is produced in the patients at the 
correct molecular weight. The ODA intermediate chain, DNAI2 and IDA light 
intermediate chain, DNALI1 are reduced in the patients. The interactor proteins 
of Dyx1c1, Sept2 and Ktu, were not reduced in abundance in the patients. 
Interaction of Dyx1c1 between Sept2 and Ktu was studied heterologously to 
demonstrate a reduction in their association with Dyx1c1 mutant protein. Thus, 
DYX1C1 is an essential ciliary protein required for the cytoplasmic preassembly 
of both the ODAs and IDAs.  
4.2 Introduction 
Primary ciliary dyskinesia (PCD [MIM 244400]) is a genetically heterogeneous 
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autosomal-recessive disorder affecting 1 in 15,000–30,000 births and is caused 
by abnormal function of motile cilia and flagella. Abnormal motility is associated 
with axonemal ultrastructural defects, giving rise to symptoms including 
pulmonary disease, which is due to impaired mucociliary transport in the airways. 
Mutations that cause PCD have been reported in 19 genes, all of which are 
associated with various ultrastructural defects, mutations in which might 
contribute to syndromic PCD. These 19 genes include those encoding axonemal 
proteins of the ODA or its docking complex (DNAH5, DNAH11, DNAI1, DNAI2, 
DNAL1, TXNDC3, and CCDC114), the radial spoke heads (RSPH4A and 
RSPH9), the central-pair apparatus (HYDIN), or the nexin-dynein regulatory 
complexes (CCDC164, CCDC39, and CCDC40). A distinct set of six proteins 
altered in PCD are either solely localized to the cytoplasm or found in both the 
cytoplasm and the axoneme: DNAAF1 (LRRC50), DNAAF2 (KTU), DNAAF3, 
CCDC103, HEATR2, and LRRC6. These are most likely involved in the 
cytoplasmic preassembly of dynein-arm complexes prior to their movement into 
the axoneme and/or in axonemal transport and attachment processes for the 
dynein-arm complexes.  
Our results described in Chapter 2 and 3 suggest that Dyx1c1 can also be 
considered as an axonemal dynein assembly factor due to its cytoplasmic 
localization and its involvement in ciliary motility. Studies performed using the 
morpholino-mediated knockdown approach in zebrafish, confirmed an 
evolutionarily conserved role of Dyx1c1 in the ciliary function. Morpholino-
mediated knockdown of zebrafish dyx1c1 resulted in hydrocephalus, kidney cysts 
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and body-axis curvature, phenotypes consistent with ciliary dysfunction in 
zebrafish. Morpholino-mediated knockdown of dyx1c1 also produced laterality 
defects in dyx1c1-morphant embryos at 48 h post-fertilization140.  
Owing to the conservation of function of Dyx1c1 in mice and zebrafish, studies 
were initiated to search for mutations in DYX1C1 in humans with PCD. DYX1C1, 
located on chromosome 15q21.3, comprises ten exons (translation starts in exon 
2) and encompasses 77.93 kb of genomic DNA. A total of nine human DYX1C1 
mutations were identified as shown in Fig. 4-1a. Apart from a 3.5-kb deletion and 
a splice-site mutation, the other seven mutations were predicted to cause 
premature protein termination and clustered toward the middle of the 420-amino-
acid sequence, between amino acids 128 and 195 (Fig. 4-1b). Thus, seven of 
the nine identified mutations are predicted to result in a truncated DYX1C1 
protein that would lack more than half of the protein, including the C-terminal 
tetratricopeptide-repeat (TPR) domain. The TPR domains in DYX1C1 have been 
shown previously to be functionally important domains required for the activities 
of DYX1C1 in neuronal motility, its cellular localization and its interaction with 
molecular chaperones. All the 12 individuals with biallelic DYX1C1 mutations 
suffered from classical symptoms of PCD, including recurrent upper and lower 
airway disease and bronchiectasis. Thus, DYX1C1 deficiency in humans causes 
disruption of left-right body asymmetry, similar to the findings observed in mice 
and zebrafish. 
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In addition to the above already published data regarding the mutations identified 
in DYX1C1 causing PCD in humans, our collaborators identified a novel mutation 
in DYX1C1 p.L19Q (unpublished). This mutation was recently identified in an in-
bred family belonging to the Druze community of the Golan Heights in Israel. The 
patients with this mutation suffer from the classical PCD symptoms of recurrent 
upper and lower respiratory tract infections. This point mutation p.L19Q leads to 
the substitution of Glutamine for Leucine in the p23 domain of DYX1C1, which is 
                  
Figure 4-1: DYX1C1 mutations in PCD patients. (a) Schematic presentation of 
chromosome 15 and the genomic structure of DYX1C1. The positions of 8 identified 
mutations are indicated by black arrows, the position of the 3.5kb deletion is indicated 
by a rectangle. (b) Schematic showing the relative positions of seven DYX1C1 
nonsense mutations identified in PCD patients and families in the DYX1C1 coding 
sequence. All mutations are clustered in the middle of DYX1C1 coding sequence and 
each mutation predicts to cause a premature stop prior to the tetricopeptide repeat 
domains (TPR) at the C-terminus of DYX1C1 (CS: p23-like C-terminal CHORD-SGT1 
domain). (Adapted from Tarkar et al. 2013) 
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a domain belonging to the heat shock protein family. This mutation leading to 
non-polar to polar switch of amino acid, might disrupt the intermolecular contacts 
leading to altered native structure of the Dyx1c1 protein. It might also potentially 
have an effect on the interactions of Dyx1c1 protein mediated by the p23 domain. 
It is hence critical to evaluate the protein expression of Dyx1c1 in the patients as 
well as assess the interactions of Dyx1c1 with its known interactors, to gain 
insights into the function of Dyx1c1.   
4.3 Results: 
4.3.1 Expression profile of Dyx1c1 protein in the Druze mutant  
 
Mutations in DYX1C1 have been identified that are known to cause PCD in 
humans; however all the previously known human mutations are postulated to 
generate either a truncated protein product lacking the C-terminal TPR domains 
or led to non-sense mediated decay. The novel DYX1C1 mutation p.L19Q is 
identified in the p23 domain of Dyx1c1, and hence it is interesting to evaluate 
whether this mutation leads to degradation or a truncated Dyx1c1 protein product. 
In order to characterize the mutation heterologously, we obtained a plasmid 
construct of Dyx1c1 harboring this mutation (Dyx-Mut). To assess for the protein 
expression, we transfected this construct in HEK cells and performed western 
blot analysis. We thus confirmed that Dyx-Mut construct produced Dyx1c1 
protein product at the correct size as evident from the two controls: a control 
Dyx1c1 plasmid and the tracheal lysate from Dyx1c1 wildtype mouse (Fig. 4-2a).  
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We obtained the respiratory epithelial cells of the patients and control from our 
collaborators. These cells were pelleted and lysates were prepared according to 
the procedures described in methods section of this chapter. Immunoblot 
analysis on the patient lysates showed that Dyx1c1 protein was produced in the 
patients and the Dyx1c1 protein band was observed at the correct molecular 
weight of 48KDa compared to the control patient (Fig 4-2b). We also quantified 
the abundance of DYX1C1 by normalizing the expression of DYX1C1 to that of 
GAPDH (Fig. 4-2c). These results suggest that the Dyx1c1 protein produced in 
the patients might be folded incorrectly that might affect its downstream 
        
Figure 4-2: DYX1C1 protein is produced in the PCD patients. (a) Western blot 
analysis shows DYX1C1 protein is expressed in the p.L19Q mutant condition at 
48KDa. (b) Western blot analysis on the patient lysates shows that DYX1C1 is 
expressed in the patients. (c) Quantification of the expression levels of DYX1C1 
normalized to GAPDH. GAPDH was used as a loading control. 
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interactions with other proteins.  
4.3.2 Expression profile of axonemal dyneins and the known interactors of 
Dyx1c1 
 
Mutations in the cytoplasmic assembly factors lead to absence of the outer and 
inner dynein arms in the mutant cilia. In some mutant cilia, these arms are 
completely absent in the axoneme; whereas some others show a reduction in the 
number of both outer and inner dynein arms. It is thought that the cytoplasmic 
abundance of the axonemal dyneins might provide useful information on the 
assembly of the dynein arms. Studies show that in case of a defect in the dynein 
arm assembly, there is either a decrease or increase in the abundance of the 
axonemal dyneins in the cytoplasm of the mutant compared to the control. The 
chaperones work with the assembly factors to aid in the correct assembly of the 
dynein motor complexes. However, due to defects in the assembly process, the 
dynein arms do not get assembled and thus are not transported into the 
axoneme of the cilia56,141.  
We investigated the expression of the ODA intermediate chain subunit DNAI2 
(Fig. 4-3a) and the IDA light intermediate chain subunit DNALI1 (Fig. 4-3a) in the 
lysates obtained from the patient samples, using Gapdh as a loading control. It 
was interesting to find that both the axonemal dynein subunits DNAI2 and 
DNALI1 were reduced in the patients compared to the control (Fig. 4-3b). The 
change in the axonemal dynein abundance was quantified by normalizing with 
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GAPDH. The reduction in the abundance of the dynein subunits indicates a 
defect in the preassembly of the axonemal dyneins in the cytoplasm or their 
subsequent transport.  
   
We have previously shown that Dyx1c1 interacts with an assembly factor 
DNAAF2/ Ktu140, which is known to play a role in the assembly of the dynein 
arms by acting as a co-chaperone and assisting in either folding or stabilization 
of the dynein subunits. The dynein assembly is a multi-step process requiring the 
axonemal dyneins, assembly factors and the chaperones. This is an orchestrated 
                        
Figure 4-3: Reduction in the levels of the ODA subunit DNAI2 and IDA subunit 
DNALI1 from the patients. (a) Western blot analysis performed using anti-DNAI2 
and anti-DNALI1 exhibit reduction in the abundance of these subunits. GAPDH was 
used as a loading control. (b) Quantification of the abundance of DNAI2 and DNALI1 
normalized to GAPDH. 
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process wherein the interactions of all the components are critical for the dynein 
arm generation. After the dynein arm is assembled, it is transported to the 
Septin-containing transition zone where the quality control of the dynein arm is 
performed. Our mass spectrometric results (described in Chapter 3) show that 
Dyx1c1 interacts with one protein of the Septin family, Septin2. The entire 
process of assembly and transport of the dynein arms is crucial for the ciliary 
motility, and any defect in either of these processes can adversely affect the 
function of cilia. 
We investigated the expression profile of the above two interactors of Dyx1c1, 
Ktu and Sept2, to assess for their altered abundance in the Druze patient 
samples. Intriguingly, we found that both Ktu and Sept2 were expressed at the 
same levels in the patients compared to the control and were detected at the 
correct size (Fig 4-4a,b).   
 
 
Figure 4-4: Expression profile of SEPTIN2 and KTU in the patient samples. 
Western blot analysis of the patient samples using anti-SEPT2 (a) and anti-KTU (b) 
antibodies show that the levels of these proteins are unchanged in the patients 
compared to the control. GAPDH was used as a loading control. 
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4.3.3 Interaction analysis of Dyx1c1 with known interactors  
 
Our results suggest that the Dyx1c1 protein in the Druze patient population is 
probably misfolded that could potentially alter the interactions of Dyx1c1 with 
other proteins in turn affecting the assembly of the dynein arms. We hence 
investigated the interactions of Dyx1c1 mutant construct with its previously 
identified interactors Ktu and Sept2 in heterologous expression system. These 
proteins are known to function in ciliogenesis and/or dynein assembly and 
transport. We co-transfected HEK cells with either the myc-tagged wildtype or 
mutant construct of Dyx1c1 along with flag-tagged Sept2 or Ktu. We performed 
immunoprecipitation experiments using anti-Dyx1c1 antibody to pull down 
Dyx1c1 and probed for either Sept2 or Ktu. Even though the expression levels of 
Ktu and Sept2 in the patients were not altered, we found that the interaction of 
Dyx1c1 with Sept2 and Ktu was reduced in the mutant condition compared to the 
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Figure 4-5: Interaction of DYX1C1 with SEPT2 and KTU is reduced in the mutant 
condition. (a) Co-immunoprecipitation and western blot analysis shows weaker 
interaction of DYX1C1-p.L19Q-myc and SEPT2 compared to the control DYX1C1-
myc condition. (a) Co-immunoprecipitation and western blot analysis shows weaker 
interaction of DYX1C1-p.L19Q-myc and KTU compared to the control DYX1C1-myc 
condition. (c) Quantification of interaction of SEPT2 and KTU with DYX1C1 
normalized to the immunoprecipitated DYX1C1. Student’s T-test, P-value <0.05 (**); 
P-value <0.001 (***). 
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In order to quantify the interaction of Dyx1c1 and Ktu or Sept2, we first got the 
percentage ratio of the intensity of Sept2 or Ktu in the immunoprecipitates to the 
intensity of Sept2 or Ktu in the input and then normalized that to the percentage 
of Dyx1c1 protein that was immunoprecipitated. We found a 60% reduction in the 
interaction of Dyx1c1 to Sept2 in the mutant condition compared to the control; 
while the interaction of Dyx1c1 to Ktu exhibited a 75% decrease in the interaction 
(Fig. 4-4c). Thus, we speculate that the Dyx1c1 function in the cilia is probably 
mediated by its interactions with Ktu and Sept2. These proteins constitute a 
group of proteins of the ciliary cytoplasm; hence it strengthens our hypothesis 
that Dyx1c1 functions as a cytoplasmic assembly factor.  
4.4 Discussion  
 
In the present study, a novel mutation in Dyx1c1 (p.L19Q) that is causative of 
PCD in humans is characterized. The Dyx1c1 gene is conserved among mice, 
zebrafish and humans. Dyx1c1 is identified as a protein essential for the motility 
of cilia; the absence of which leads to absence of inner and outer dynein arms in 
the ciliary axoneme. The phenotypic similarity of the Dyx1c1 mutants in three 
organisms examined suggests that Dyx1c1 functions for dynein arm pre-
assembly. We initially assessed whether the Dyx1c1 protein was produced in the 
nasal respiratory epithelial cells of the patients harboring this mutation. 
Intriguingly, we found that Dyx1c1 protein was expressed in the patients at the 
appropriate molecular weight (48KDa). The plasmid construct with this mutation, 
when transfected into HEK cells also expressed the DYX1C1 protein.  
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Ciliary axonemes of the PCD patients with this mutation exhibited a loss of the 
outer and inner dynein arms. The mutant cilia lacked the expression of the ODA 
heavy chain DNAH5 as well as the IDA light intermediate chain DNALI1 in the 
axoneme. We characterized the protein expression levels of the ODA and IDA 
subunits DNAI2 and DNALI1 respectively in the patient samples and observed 
reduced abundance of these two proteins in the mutant samples compared to the 
control. Densitometric analysis exhibited a 72% reduction in the expression of 
DNAI2, while a 99% decrease in DNALI1. The reduction in the abundance of the 
axonemal dynein subunits has been implicated in a faulty assembly of the dynein 
arms in the mutant cilia due to the loss of the subunit incorporation into the 
dynein motor complex or altered rates of degradation. We thus gathered 
additional evidence of the role of DYX1C1 in the cytoplasmic preassembly of the 
ciliary dyneins due to the reduction in the subunit abundance.  
Our biochemical analyses provided additional insight into the proposed function 
of Dyx1c1 as a facilitator of dynein pre-assembly, by revealing defects in the 
association of mutant Dyx1c1 with Sept2 and Ktu. The finding of reduced ODA 
intermediate chain and IDA light intermediate chain abundance in the mutant is 
consistent with an altered pre-assembly process. Intriguingly, no change in the 
expression pattern of Sept2 and Ktu was observed in the mutant when compared 
to the wildtype. Furthermore, immunoprecipitation demonstrated an interaction 
between Dyx1c1 and Ktu as well as Sept2 in the control condition however, a 
substantial reduction in the interaction was observed in the mutant condition. 
Because Hsp70 and Hsp90 were found to be interacting proteins of Dyx1c1 and 
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Ktu, Dyx1c1 could work as a co-chaperone to localize general functions of 
molecular chaperones (holding, assembling and protecting of proteins from 
degradation) to dynein arm formation with the help of Ktu. The reduced 
interaction might implicate decreased transfer of the correctly assembled dynein 
arms in to the axoneme. Although much progress has been made in 
understanding the mechanisms of IFT responsible for the transport of the dynein 
arms, very little is known about the cytoplasmic process for pre-assembly of 
dynein complexes. Dyx1c1 point mutant will thus aid in understanding this 
cytoplasmic process. 
4.5 Methods: 
4.5.1 Protein lysates for human respiratory epithelial cells 
 
Human respiratory cells were obtained by nasal brushing. The suspension 
containing the nasal respiratory cells were centrifuged at 20,000xg at 4oC for 10 
min to pellet the cells. The cells were then washed 2 times with PBS to remove 
any mucus or storage buffer. The cells were again centrifuged 20,000xg at 4oC 
for 10 min and the pellet was incubated in RIPA lysis buffer containing protease 
inhibitor cocktail. The lysates were incubated on ice for 20 min, following which 
the lysates were spun down to pellet the debris. The concentration of the protein 
lysates was obtained by BCA assay.   
4.5.2 Plasmids  
 
The DYX1C1-WT and DYX1C1-p.L19Q plasmids were obtained from Dr. Hannah 
Mitchision. DYX1C1-WT and DYX1C1-p.L19Q sequences were further amplified 
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using primers incorporating myc epitope tagged sequence and then subcloned 
into pCAG vector to create pCAG- DYX1C1-WT-myc and pCAG-DYX1C1-
p.L19Q-myc plasmids. The Sept2-flag plasmid was constructed as described 
previously (Chapter 3). The flag-tagged DNAAF2 plasmid was a gift from Dr. 
Heymut Omran. The sequence of all plasmids was confirmed by sequencing.  
4.5.3 Cell culture and transfection 
 
Human embryonic kidney (HEK293T) cells were grown to confluence in DMEM 
supplemented with 10% FBS, 1% non-essential amino acid (NEAA) and 1% 
penicillin-streptomycin antibiotics (Invitrogen). Cultures were plated at a density 
of 106 cells on a 10-cm petridish. DNA (24 µg) was added to the petridish with 75 
µl of Lipofectamine 2000 reagent (Invitrogen) in OptiMEM-1. The transfection mix 
was added to cells in normal growth media and incubated for 48 h at 37 °C. To 
obtain the protein lysates from the cells, the normal growth media was removed 
and the cells were washed with PBS. The cells were then collected, centrifuged 
to pellet the cells and the pellet was incubated in RIPA buffer supplemented with 
1X Proteinase Inhibitor Cocktail for 20 min on ice. The lysates were then 
centrifuged at 2000xg to pellet the debris. Protein blots were also performed on 
the transfected cells as described above. 
4.5.4 Western blotting 
 
Proteins were separated on 10% SDS-PAGE minigels and then transferred to 
Immobilon (Millipore) membrane for protein blotting. For detecting DYX1C1 
protein, the antibody to N-terminal DYX1C1 (Sigma, SAB4200128) was used at a 
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dilution of 1:200; antibody to GAPDH (Sigma, G8795) was used at a 1:1,500 
dilution as a loading control; monoclonal antibody to DNAI2 (Abnova, M01, clone 
1C8; 1:500 dilution), c-myc antibody (Sigma, C3956, 1:500 dilution), c-myc 
antibody mouse monoclonal (Sigma, M4439, 1:750 dilution), antibody to flag 
produced in rabbit (Sigma, SAB1306078, 1:1000 dilution), and mouse 
monoclonal anti-flag antibody (Sigma, F4042, 1:500 dilution). LI-COR Odyssey 
infrared secondary antibodies (goat antibody to mouse 680 (926-32220), goat 
antibody to mouse 800 (926-32210) goat antibody to mouse 680 (926-32221) 
and goat antibody to mouse 800 (926-32211)) were used at dilutions of 1:10,000. 





Immunoprecipitation assays were performed using the Dynabeads Protein G 
Immunoprecipitation kit (Invitrogen). Briefly, Dynabeads were resuspended in the 
vial and separated on a magnet from solution. Antibody to Dyx1c1 (Sigma, 
SAB4200128), (5 µg) was diluted in 200 µl of Washing and Binding Solution and 
incubated with rotation for 120 min at room temperature. Bead-antibody 
complexes were separated on the magnet, washed by gentle pipetting and 
separated. Protein lysates were incubated with the bead-antibody complexes 
overnight at 4 °C. Bead-antibody-antigen complexes were then washed using the 
washing solution three times. Complexes were then incubated with elution buffer 
for 10–15 min to dissociate them. Beads were separated on a magnet, and 
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supernatant containing the proteins was separated by SDS-PAGE and analyzed 
by protein blotting using monoclonal antibody to antibody to flag produced in 
rabbit (Sigma, SAB1306078, 1:1000 dilution), and mouse monoclonal anti-flag 
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5. DYX1C1 (DNAAF4) IS REQUIRED FOR ASSEMBLY OF 
LIGHT AND INTERMEDIATE CHAIN AXONEMAL 
DYNEINS IN TRACHEAL EPITHELIAL CELLS 
 
5.1 Abstract: 
Genetic evidence indicates that cytoplasmic preassembly of axonemal dyneins 
requires proteins encoded by the genes DNAAF1/LRRC50, DNAAF2/KTU, 
DNAAF3 and DYX1C1/DNAAF4. These assembly factors are thought to act as 
co-chaperones that promote the assembly of large macromolecular axonemal 
dynein complexes in the cytoplasm prior to transport into the cilia. In this study, 
we have investigated the role of Dyx1c1 in preassembly of components of the 
outer dynein arm (ODA) complex. Dyx1c1 interacts with intermediate and light 
chain subunits of the ODA complex in the cytoplasm of tracheal epithelial cells. 
Light and intermediate chains fail to form complexes in the cytoplasm of tracheal 
epithelial cells of Dyx1c1 mutants. Dyx1c1 increases by four fold the association 
of Light chain subunits Dnal1 and Dnal4 in heterologously expressing HEK 293-T 
cells. Finally, a novel Primary Ciliary Dyskinesia (PCD) patient associated 
missense mutation in Dyx1c1 is impaired in its ability to assembly Dnal1 and 
Dnal4. In conclusion, we identify a step in ODA pre-assembly in which Dyx1c1 
facilitates formation of light and intermediate chain dynein complexes. 
5.2 Introduction: 
Failure to assemble the outer and inner dynein arms of motile cilia causes 
Primary Ciliary Dyskinesia (PCD), a ciliopathy characterized by defects in 
multiple organ systems. The axonemal dynein assembly factors identified largely 
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through genetic studies have been classified into three general categories: i) 
cytoplasmic proteins required for the preassembly of outer and inner dynein 
complexes (e.g. DNAAF1, DNAAF2, DNAAF3 and 
DNAAF4/DYX1C1)102,104,138,140; ii) adaptor proteins involved in the transport of the 
assembled 2MDa dynein motor complex (ODA16)58,62; and iii) proteins of the 
axoneme that assist in the docking of the assembled dynein arms to the 
microtubular scaffold at appropriate sites (e.g. DC)106,151,152. The molecular 
details of axonemal dynein assembly, especially the stages in the cytoplasmic 
preassembly process, that each of the DNAAF proteins serve is not yet 
completely defined.  
The outer dynein arms (ODAs) of motile cilia are composed of either two (e.g. 
mammals and sea urchins) or three (e.g. Chlamydomonas and Tetrahymena) 
dynein heavy chain (HC) molecules; two WD-repeat intermediate chains (ICs) 
and multiple light chains (LCs)32,33,36,58. In Chlamydomonas, one distinct type of 
ODA complex is known to contain three HCs (alpha, beta and gamma-HC), two 
ICs, nine LCs and three docking complex proteins. Based on homolog searches, 
five ODA HC orthologs of Chlamydomonas beta and gamma chains have been 
identified in humans. In humans and mice DNAI1, DNAI2 and TXNDC3 are the 
three known IC subunits, and DNAL1, TCTE3, DYNLRB1/2, DYNLL1/2, 
DYNLT1/2 and DNAL4 form the group of LC subunits of the ODA. Genetic 
studies have shown that mutations in several ODA complex dynein subunits 
cause PCD: i) DNAI1153, OMIM ID: 604366, ii) DNAH5154, OMIM ID: 603335, iii) 
DNAH1192, OMIM ID: 603339, iv) thioredoxin domain containing 395 (TXNDC3, 
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OMIM ID: 607421), v) DNAI293, OMIM ID: 605483 and vi) DNAL1155, OMIM ID: 
610062. Mutations in DNAI1, DNAI2, DNAL1 and DNAH5 cause an ODA 
deficiency in PCD patients leading to ciliary immotility. In contrast, DNAH11 
mutations did not result in ultrastructural defects in cilia and TXNDC3 mutant cilia 
exhibited both normal and ODA-deficient cross sections. TXNDC3 is proposed to 
function as one of the two distinct ODAs in humans.  
Cytoplasmic preassembly of the ODA complex is thought to be a sequential 
process wherein the intermediate chain subunits first assemble, followed by 
assembly of the heavy chain subunits, and finally light chains are incorporated to 
form a functional ODA motor complex that is competent for attachment to the 
ciliary doublet microtubules. The docking complex comprising 3 proteins helps 
assemble the motor complex on the doublet microtubules. In addition to the 
individual dynein chain, the process requires both chaperones and the 
specialized assembly factors, DNAAFs56,156. Mutations in most dynein chains 
interfere with the association of the remaining subunits into a complex in the 
cytoplasm and block subsequent transport of this complex into the axoneme. 
Mutations identified in assembly factors (DNAAF1/Lrrc50, DNAAF2/Ktu, DNAAF3 
and DNAAF4/Dyx1c1) lead to the absence of ODAs from the mutant axoneme 
due to a faulty assembly of the ODA motor complex in the mutant cytoplasm. A 
mutation in the assembly factor DNAAF1/Lrrc50/Oda7, a leucine-rich repeat 
protein that localizes to the cell body, caused decrease in the abundance of one 
of the heavy chain subunits in the cytoplasm without affecting levels of other 
heavy chains and intermediate chain subunits. A partial co-assembly of the 
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remaining heavy and the intermediate chains was observed in Oda7 
mutants58,157,158. Ktu/PF13/DNAAF2, a cytoplasmic assembly factor belonging to 
the PIH protein group, is hypothesized to act as a co-chaperone in dynein 
assembly within the cytoplasm as it interacts with Hsp70. Studies show that all 
three ODA heavy chain subunits are depleted from pf13 mutants, while the 
intermediate chains are overabundant. Immunoprecipitation experiments show 
that intermediate and light chains preassemble in the pf13 mutants, however 
heavy chains are not assembled suggesting that KTU may be involves in heavy 
chain assembly but not light and intermediate chain assembly60,61,156. A third 
dynein assembly factor DNAAF3/Pf22 is specifically required for the proper 
folding of the individual HCs for their subsequent association into larger, multi-
subunit complexes with the ICs and LCs46,102. DNAAF1, DNAAF2 and DNAAF3 
thus appear to facilitate folding of the dynein heavy chains that are then 
assembled into an ODA complex in the presence of chaperones.  Factors that 
similarly contribute to assembly of light and intermediate chains have yet to be 
defined.  
Mutations in Dyx1c1 are identified that cause PCD in humans and PCD-like 
phenotypes in mouse and zebrafish. Immunofluorescence analysis revealed that 
Dyx1c1 localizes to the cytoplasm of mouse respiratory epithelial cells. DYX1C1 
interacts with the E3 ubiquitin ligase CHIP, HSP70, HSP90, and KTU/DNAAF2 
consistent with function as a cytoplasmic assembly factor128,129. Together, these 
findings suggested that DYX1C1/DNAAF4 is an essential component of the 
ciliary dynein cytoplasmic pre-assembly process159. Dyx1c1 mutant ciliary 
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axoneme exhibit the lack of the ODA components DNAH9, DNAH5 and 
DNAI2160; but the assembly state of heavy, light and intermediate chain dyneins 
in the cytoplasm of the Dyx1c1 mutants has not been previously defined.  
In this study we provide evidence that DYX1C1 promotes assembly of axonemal 
light chains in the cytoplasm of tracheal epithelial cells.  We find that Dyx1c1 
interacts with the ODA intermediate chain subunits Dnai1 and Dnai2 and light 
chain subunits Dnal1 and Dnal4 in tracheal epithelial cells. Tracheal epithelial 
cells in mutants have reduced levels of light and intermediate chains, and light 
and intermediate chains fail to assemble in mutants.  To further test whether 
DYX1C1 specifically promotes assembly of light chains we co-expressed 
DYX1C1 or other DNAAFs in HEK293 cells along with axonemal dynein light 
chains. DYX1C1 promoted the highest level of light chain association in Hek293 
cells compared to all other DNAAFs, and this activity was reduced by DYX1c1 
mutations. Based on this data, we propose a model wherein Dyx1c1 assembles 
the light chain subunits Dnal1 and Dnal4 in an early step in ODA preassembly.  
5.3 Results: 
5.3.1 Dyx1c1 interacts with axonemal dynein subunits of the ODA complex 
in the cytoplasm of tracheal epithelial cells 
 
Previous studies have suggested that mutations in dynein assembly factors could 
either prevent the dynein arm complex from preassembling in the cytoplasm and 
that dynein assembly factors might play a role in the assembly of the dynein 
subunits; either by directly interacting with them, or in an indirect, chaperone-
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mediated fashion. More direct biochemical analysis of Dyx1c1 function depends 
on the cytoplasmic pool of the axonemal dyneins.  In order to identify the role of 
Dyx1c1 in the cytoplasm, we developed a protocol for separation of the ciliary 
axonemes from the trachea of Dyx1c1 wildtype and knockout mouse. We thus 
obtain two fractions after the deciliation workflow: i) cytoplasmic fraction 
containing the trachea stripped off the ciliary axoneme and ii) axonemal fraction 
consisting of the ciliary axoneme. We found that the wildtype and knockout 
axonemal fraction had little or no contamination of the cytoplasmic fraction and 
vice-versa.  
We investigated the role of Dyx1c1 in the ODA pre-assembly in the tracheal 
cytoplasm. Since some of the assembly factors associate with one or more of the 
axonemal dynein subunits themselves, we found it important to evaluate for an 
interaction of Dyx1c1 with the intermediate and light dynein chain subunits of the 
outer dynein arm complex (Fig. 5-1). We investigated the interaction of Dyx1c1 
with the dynein subunits in the cytoplasmic fraction obtained from the WT and 
KO trachea. We performed immunoprecipitations using the anti-Dyx1c1 antibody 
to pull down the Dyx1c1 protein from the wildtype and knockout Dyx1c1 tracheal 
cytoplasmic fractions. Since the Dyx1c1 protein is not expressed in the KO 
mouse trachea, the immunoprecipitation from the KO cytoplasm acts as the 
control. We looked for the interaction of Dyx1c1 with the ODA light chain subunits 
Dnal1 and Dnal4; and found that Dyx1c1 interacts with both the dynein light 
chain subunits Dnal1 and Dnal4. When we tested for the interaction of the 
Dyx1c1 with the intermediate chain subunits of the ODA Dnai1, Dnai2 and 
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Txndc3, we found that Txndc3 does not co-immunoprecipitate with Dyx1c1. 
However, the two other dynein intermediate chain subunits Dnai1 as well as 
Dnai2 co-precipitate with Dyx1c1 (Fig. 5-1). We thus show that Dyx1c1 needs to 
associate with intermediate and light chain dynein subunits for its function as a 
dynein cytoplasmic assembly factor.  
 
5.3.2 Dyx1c1 require C-terminal TPR containing domains to interact with 
ODA light chains Dnal1 and Dnal4 
We assessed the interactions of Dyx1c1 with the ODA light chains Dnal1 and 
Dnal4 in a heterologous expression system. The Dyx1c1 protein has an N-
terminal p23 domain similar to the heat shock protein family domains and C-
terminal TPR domains that are known to mediate protein-protein interactions. 
                              
Figure 5-1 Interaction of Dyx1c1 with intermediate and light chain subunits of 
the outer dynein arm. Co-immunoprecipitation and western blot analysis indicates 
that Dyx1c1 interacts with ODA light chains Dnal1 and Dnal4; ODA intermediate 
chains Dnai1 and Dnai2; but not with Txndc3. 
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Biallelic mutations identified in Dyx1c1 that caused PCD in humans were found 
between amino acids 128 and 195 of the 420-amino acid Dyx1c1 protein. These 
mutations are thus predicted to lead to a truncated protein product devoid of the 
TPR domains. Studies characterizing the role of Dyx1c1 in the developing rat 
neocortex showed that knockdown of Dyx1c1 leads to abnormal neuronal 
migration and this phenotype can be rescued by overexpressing the TPR 
domain-containing region of Dyx1c1. Additionally the TPR domains have been 
shown to be important for interaction of Dyx1c1 with the chaperones.  
We tested three Dyx1c1 constructs fused with GFP; one full-length; one N-
terminal deletion missing the p23 domain; and the other C-terminal deletion 
construct lacking the TPR domains; as shown in the schematic in Fig. 5-2a for 
the interaction with Dnal1 and Dnal4 by co-immunoprecipitation. Dnal1 and 
Dnal4 were incorporated into the vector with chicken actin gene promoter with 
flag and myc epitope-tags (pCAG-Dnal1-flag and pCAG-Dnal4-myc) respectively. 
To test for the interaction of Dyx1c1 with the light chains Dnal1 and Dnal4, we 
co-transfected HEK 293T cells with full-length Dyx1c1 (pCAG-Dyx1c1-GFP) 
construct with either pCAG-Dnal1-flag or pCAG-Dnal4-myc. We also co-
transfected either of the light chains with pCAG-GFP plasmid as a control. We 
immunoprecipitated the Dyx1c1 protein using the anti-GFP antibody and probed 
with Dnal1 or Dnal4 antibody. We found that Dyx1c1 interacts with Dnal1 and 
Dnal4 both independently co-precipitate with Dyx1c1 (Fig. 5-2b, d). We found a 
9-fold increase in the interaction between Dnal1 and Dyx1c1, whereas a 5-fold 
increase was observed in the association of Dnal4 and Dyx1c1 compared to the 
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GFP control condition. We further investigated the interaction of the Dnal1 and 
Dnal4 with the truncation constructs of Dyx1c1. We co-transfected the dynein 
light chains Dnal1 or Dnal4 with one of the following: full-length, N-terminal or C-
terminal truncation constructs of Dyx1c1. We then performed 
immunoprecipitation experiments using anti-GFP antibody and probed for Dnal1 
or Dnal4 (Fig 5-2c, e). The interaction of both Dnal1 and Dnal4 with the p23 
domain of Dyx1c1 was reduced by about 75% when normalized to their 
association with full-length Dyx1c1. Interestingly, both the Dnal1 and Dnal4 were 
found to co-precipitate with the TPR domain-containing construct of Dyx1c1. The 
TPR domains of Dyx1c1 are thus necessary and sufficient for the interaction of 









Figure 5-2: Heterologous interaction of Dyx1c1 with ODA light chain subunits 
Dnal1 and Dnal4. (a) Schematic of Dyx1c1 full-length and truncation constructs 
fused to GFP. Co-immunoprecipitation and western blot analysis shows that Dyx1c1 
interacts with Dnal1 (b) and Dnal4 (d). Co-immunoprecipitation and western blot 
analysis shows that Dyx1c1 interacts with Dnal1 (c) and Dnal4 (e) through the TPR 
domains of Dyx1c1. 
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5.3.3 Light and intermediate dynein subunits of the ODA complex fail to 
assemble in the Dyx1c1 knockout tracheal epithelial cell cytoplasm 
 
The mutant cilia of the previously identified axonemal dynein assembly factors 
(DNAAF1, DNAAF2, DNAAF3) have all shown absence of the outer and inner 
dynein arms in the axoneme due to a defect in the chaperone-dependent 
cytoplasmic preassembly of the ODA or IDA complex. Since Dyx1c1 localizes to 
the cytoplasm of the ciliated respiratory epithelial cells and interacts with the heat 
shock proteins Hsp70 and Hsp90, it is hypothesized to play a role in promoting 
axonemal dynein subunit preassembly. We thus investigated the assembly state 
of the ODA complex in the cytoplasm of the Dyx1c1 knockout trachea. To assess 
the association of the light chain subunits Dnal1 and Dnal4, we co-
immunoprecipitated the light chain subunit Dnal1 using anti-Dnal1 antibody and 
probed for Dnal4 as well as Dnal1. We found that Dnal4 co-precipitated with 
Dnal1 in the WT cytoplasm, while it failed to interact in the KO cytoplasm. In 
order to evaluate the interaction of Dnal1 to Dnal4 quantitatively, we analyzed the 
percentage intensity ratio of immunoprecipitated Dnal4 to its input and 
normalized that to the percentage intensity ratio of immunoprecipitated Dnal1 to 
its input. The interaction between Dnal1 and Dnal4 was reduced by ~85% in the 
knockout cytoplasm indicating a faulty assembly of the light chain subunits (Fig. 
5-3a).  
We further assessed the interaction amongst the intermediate chain subunits of 
the ODA complex for which we immunoprecipitated one of the IC subunits and 
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blotted for the presence of the other IC subunit. Here we investigated the 
interaction between the IC subunits Dnai1 and Dnai2 as well as Txndc3 and 
Dnai2. We immunoprecipitated the IC subunit Dnai2 from the WT and KO 
cytoplasmic extracts and probed with Dnai1 and Txndc3 to analyze their 
interaction with Dnai2. Dnai1 and Dnai2 interact in the WT cytoplasm while this 
interaction is diminished in the KO cytoplasm. After quantitative analysis of the 
interaction of Dnai1 and Dnai2 as previously described, we identified that 
interaction was reduced to ~1% in the KO cytoplasm compared to the 34% 
association in the WT cytoplasm (Fig. 5-3b). Txndc3 and Dnai2 were found to 
assemble in the WT cytoplasm and failed to associate in the KO. The interaction 
between these two subunits was reduced by almost 99% in the KO cytoplasm 
when compared to the WT (Fig. 5-3c). We have shown that Txndc3 fails to 
associate with Dyx1c1 (Fig. 5-1d) but the interaction of Txndc3 with the 
intermediate chain subunit Dnai2 is altered in the mutant cytoplasm. Dyx1c1 
seems to be crucial for the interaction of the intermediate chain subunits Dnai1, 
Dnai2 and Txndc3 in the cytoplasm, even though it does not directly interact with 
Txndc3.  
Next, we examined the assembly state of the LC-IC complex of the ODA by 
assessing the interaction between IC subunit Dnai2 and LC subunit Dnal4. We 
performed immunoprecipitation of Dnal4 using anti-Dnal4 antibody from the WT 
and KO cytoplasmic extracts and probed for Dnai2. Dnai2 co-precipitated with 
Dnal4 in the WT cytoplasm, but showed reduced association in the KO 
cytoplasm. Upon quantitative analysis of the interaction, we found a 76% 
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decrease in the association of Dnai2 to Dnal4 in the KO (Fig. 5-3d). These 
results demonstrate the defect in the assembly of the light chain subunits with the 
intermediate chain subunits in the Dyx1c1 mutant cytoplasm. We thus found that 
Dyx1c1 is critical for the assembly of the ODA light chain and intermediate chain 
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Figure 5-3: Outer dynein arm fails to assemble in the Dyx1c1 knockout tracheal 
cytoplasm. (a) Co-immunoprecipitation and western blot analysis shows that Dnal4 
interacts with Dnal1 (top panel); quantification of interaction (bottom panel). (b) Co-
immunoprecipitation and western blot analysis shows that Dnai1 interacts with Dnai2 
(top panel); quantification of interaction (bottom panel). (c) Co-immunoprecipitation 
and western blot analysis shows that Txndc3 interacts with Dnai2 (top panel); 
quantification of interaction (bottom panel). (d) Co-immunoprecipitation and western 
blot analysis shows that Dnai2 interacts with Dnal4 (top panel); quantification of 
interaction (bottom panel). 
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5.3.4 Dyx1c1 induces the assembly of axonemal light chain subunits of 
Dnal1 and Dnal4 
 
We have shown earlier in Fig. 5-3a that the dynein light chain subunits Dnal1 and 
Dnal4 interact in the wildtype cytoplasm and this interaction is weakened in the 
Dyx1c1 KO cytoplasm. To obtain an insight into the function of Dyx1c1 pertaining 
to light chain assembly, we tested for the association of Dnal1 and Dnal4 in HEK 
cells. HEK cells are immortalized kidney derived cell line that possesses primary 
cilia. Since HEK 293-T cells do not normally express the axonemal dyneins or 
motile-cilia specific genes, it was interesting to evaluate whether Dyx1c1 would 
be sufficient for the association of Dnal1 and Dnal4 in these cells. We co-
transfected HEK cells with pCAG-Dnal1-flag and pCAG-Dnal4-myc with pCAG-
Dyx1c1-GFP or pCAG-GFP constructs. We then performed immunoprecipitation 
using anti-Dnal1 antibody to pull down the Dnal1 and its interacting proteins and 
probed with Dnal4, to test for Dnal1-Dnal4 interaction. We also probed the blots 
for Dnal1 for normalization and subsequent analysis of the association. In the 
absence of full-length Dyx1c1, Dnal1 and Dnal4 fail to assemble heterologously; 
interestingly Dnal1 and Dnal4 interact robustly in the presence of Dyx1c1 (Fig. 5-
4a). To obtain a quantitative measure of the interaction, we acquired percentage 
of intensity ratio of immunoprecipitated Dnal4 to its wildtype expression level and 
normalized that to the intensity ratio of immunoprecipitated Dnal1 to its wildtype 
expression level. We observed that there was a 8-fold increase in the association 
of Dnal1 and Dnal4 in the presence of Dyx1c1 compared to the GFP control 
condition (Fig. 5-4b).  
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We showed that the C-terminal TPR-containing domains of Dyx1c1 mediate the 
interaction Dyx1c1 with the individual axonemal dynein light chain subunits Dnal1 
and Dnal4. To assess the domain of Dyx1c1 required for the association of Dnal1 
and Dnal4, we co-transfected with both pCAG-Dnal1-flag and pCAG-Dnal4-myc 
constructs with either N-terminal or C-terminal truncation constructs of Dyx1c1. 
Using the anti-Dnal1 antibody, we pulled down Dnal1 protein and performed 
western blot to look for the expression of Dnal4. Unexpectedly, we found that 
Dnal1 and Dnal4 associate with each other in both the conditions (Fig. 5-4a) and 
just the TPR-domains are not sufficient for the assembly. Compared to the full-
length Dyx1c1, the Dnal1-Dnal4 association was reduced to half in the presence 
of the Dyx1c1 truncation constructs (Fig. 5-4b); indicating that both the domains 
of Dyx1c1 are required for the light chain assembly. 
We further investigated whether the interaction of Dnal1 and Dnal4 was altered in 
the presence of the novel missense mutant Dyx1c1 p.L19Q (Dyx-Mut). We co-
transfected HEK cells with the pCAG-Dnal1-flag and pCAG-Dnal4-myc along 
with point mutant construct Dyx-Mut. We then performed co-immunoprecipitation 
experiments and analysis as described earlier and found that the association of 
Dnal1 and Dnal4 was considerably reduced in the Dyx-Mut condition (Fig. 5-4a). 
Analysis of the Dnal1-Dnal4 assembly in the mutant condition exhibited a 
reduction of 62.5% when compared to the full-length Dyx1c1 condition (Fig. 5-4b).  
We next assessed whether any of the other three cytoplasmic assembly factors 
DNAAF1/Lrrc50, DNAAF2/Ktu and DNAAF3 could aid in the association of the 
light chains Dnal1 and Dnal4. HEK cells were co-transfected with pCAG-Dnal1-
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flag and pCAG-Dnal4-myc along with one of the above-mentioned assembly 
factors. After the co-immunoprecipitation and western blot analysis, we found 
that Dnal1 and Dnal4 do not associate in the presence of DNAAF1 or DNAAF3. 
Interestingly, they are found to interact in the presence of the assembly factor 
DNAAF2 (Fig. 5-4a), which is previously shown to interact with Dyx1c1. When 
normalized to Dnal1-Dnal4 assembly in the presence of full-length Dyx1c1, it was 
observed that the association was decreased by 50% in the presence of 
DNAAF2/Ktu (Fig. 5-4b). We thus show that Dyx1c1 induces the assembly of the 
dynein light chain subunits Dnal1 and Dnal4 in a heterologous expression system. 
We conclude that both the TPR and p23 domains of Dyx1c1 are required for the 
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Figure 5-4: Dyx1c1 facilitates the assembly of Dnal1 and Dnal4. (a) Interaction of 
Dnal1 and Dnal4 in the presence of full-length Dyx1c1, truncation constructs of 
Dyx1c1, Dyx-Mut and assembly factors DNAAF1, DNAAF2 and DNAAF3. (b) 
Quantification of the association of Dnal4 to Dnal1 when normalized to Dnal1. 
Posthoc analysis, P-value<0.001 (***). 
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5.4 Discussion 
Defects in the assembly of the outer and inner dynein arm complexes due to 
mutations in either the dynein subunits themselves, or the assembly factors that 
aid in the formation of the dynein complexes, lead to PCD. It has been proposed 
in previous studies performed in Chlamydomonas that the dynein arms are 
preassembled in the cytoplasm as three complexes: a heavy chain-intermediate 
chain (HC-IC) complex; a light chain complex (LC) and a docking complex (DC)56. 
According to this model, the heavy and the intermediate chain subunits exist as a 
complex in the cytoplasm and the lack of either the heavy or light chain subunit 
would lead to a defective dynein complex. The light chains would then be 
assembled onto the HC-IC complex, which would later be docked on the DC 
before being loaded on the IFT particle. Detailed characterization of the 
cytoplasmic preassembly process is required to understand ciliary motility that 
might help in the better diagnosis of PCD. Deciphering the multi-step assembly 
pathway and the proteins involved could also potentially lead to identification of 
pharmacological targets that might help PCD patients.  
Dyx1c1 has been previously identified as a cytoplasmic pre-assembly factor of 
the axonemal dyneins, the lack of which leads to the absence of both the inner 
and the outer dynein arms in the axoneme of the patients. Despite the functional 
conservation of Dyx1c1 amongst the organisms examined (mouse, humans and 
zebrafish) evident from the similar phenotypes observed, it was still unclear how 
Dyx1c1 functions in the dynein arm assembly process. It was hypothesized that 
due to the cytoplasmic localization of Dyx1c1, it plays a role in the assembly of 
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the dynein arm complex through its interactions with the heat shock proteins 
and/or its subsequent transport from the cytoplasm to the transition zone or the 
base of the cilia. The data presented in this study suggest that the assembly of 
the outer dynein arm complex requires at least the following steps: a first step in 
which the subunits are folded and stabilized; a second step wherein the subunits 
are aggregated by one or more assembly factors; and the final step that 
generates a functional complex competent for transport and binding to the 
microtubules. 
Our biochemical analyses provide an important insight into the proposed function 
of Dyx1c1 as a facilitator of dynein preassembly in the cytoplasm by identifying 
the defect in the assembly of the dynein light and intermediate chain subunits in 
the absence of Dyx1c1. It has been shown that the assembled dynein arms form 
a pool of cytoplasmic precursor that is then transferred to a loading zone around 
the basal body from where it is transported into the axoneme via IFT. Since the 
dynein arm assembly process takes place in the cytoplasm, it was critical to 
perform fractionation of the trachea into cytoplasmic extract and axonemal 
extract. We evaluated the interaction of Dyx1c1 with the light and intermediate 
chain dynein subunits by co-immunoprecipitation and western blot analysis. We 
found that Dyx1c1 fails to interact with IC subunit Txndc3, but associated with the 
other IC chains Dnai1 and Dnai2 as well as LC subunits Dnal1 and Dnal4. The 
interaction of Dyx1c1 with the IC and LC subunits is considerably reduced in the 
Dyx1c1 KO tracheal cytoplasm; thus indicating that Dyx1c1 is important for the 
assembly of the intermediate and light chain axonemal dynein subunits in the 
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cytoplasm. We also verified the interaction of the light chain subunits Dnal1 and 
Dnal4 with Dyx1c1 heterologously. Furthermore, we identified that the TPR 
domains of Dyx1c1 are critical for the light chain interaction.   
We found that the ODA complex fails to assemble in the Dyx1c1 mutant 
cytoplasm. We observed that the light chain subunits Dnal1 and Dnal4 that 
associated in the WT cytoplasm fail to assemble in the KO cytoplasm. Similarly, 
the IC subunits Dnai2 and Dnai1 as well as Dnai2 and Txndc3 that interact in the 
WT cytoplasm are found to not assemble in the KO cytoplasm. Interestingly, the 
IC-LC assembly of Dnai2 and Dnal4 was also absent in the mutant cytoplasm 
indicating a role of Dyx1c1 in the assembly of the IC-IC, LC-LC as well as IC-LC 
subunits of the ODA complex. We also observed reduced abundance of the light 
and intermediate chain subunits in the Dyx1c1 knockout cytoplasm, which is 
consistent with an altered preassembly process. Since the light chain subunits 
Dnal1 and Dnal4 interact with each other in the Dyx1c1 wildtype cytoplasm, we 
assessed whether Dyx1c1 was sufficient for their association in HEK cells. 
Interestingly, Dyx1c1 induces the assembly of Dnal1 and Dnal4 and the 
association of these two light chains requires both the p23 and TPR domains of 
Dyx1c1. A novel missense mutation identified in Dyx1c1 reduces the interaction 
between the light chains by about 60%. Previous evidence has also shown that 
in spite of the overabundance of one the heavy chain dynein subunits in the 
cytoplasm of the Ktu mutant, this subunit fails to co-precipitate with the other 
dynein subunits, suggesting an aberrant assembly process61. We also tested the 
interaction of Dnal1-Dnal4 in the presence of Ktu, an interactor of Dyx1c1, as 
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well as the other assembly factors Dnaaf1 and Dnaaf3. The association of the 
light chains was impaired in the presence Dnaaf1 and Dnaaf3, while Ktu assisted 
weakly in the assembly of the light chains.  
In conclusion, we have shown an essential role for Dyx1c1 (Dnaaf4), a 
conserved dynein assembly factor in the pre-assembly of multiple ciliary 
axonemal dyneins. Dyx1c1 function seems to be different from the other recently 
identified PCD proteins Dnaaf1, Dnaaf2, Dnaaf3 and Mot4861 in that it is 
essential for the assembly of the light chain and intermediate chain subunits (Fig. 
5-5). We propose that Dyx1c1 assembles the intermediate chains in the 
cytoplasm onto which the heavy chains get assembled. The light chains are 
assembled in the cytoplasm in the presence of Dyx1c1, which are then 
potentially targeted to the correct dynein subunit in the presence of other 
assembly factors. In summary, Dyx1c1 defines a step in the multi-stage pathway 
that is essential for the cytoplasmic assembly of the ciliary dyneins. Further 
characterization of Dyx1c1 in the assembly process is required to determine 
whether Dyx1c1 is involved in the chaperone-mediated folding of the individual 
subunits, or their association into the multi-subunit dynein arm complex.  
Because there are many dynein subunits and their isoforms that are required for 
the normal ciliary function, and the current assembly factors do not contribute to 
the formation of all the dynein complexes, there is a need for additional future 
studies to identify more assembly factor proteins.  
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5.5 Materials and Methods 
5.5.1 Deciliation of the trachea 
 
The tracheas harvested from postnatal day 16 (P16) Dyx1c1 wildtype and 
knockout mice were washed with cold phosphate-buffered saline to remove 
mucus and cell debris. Animal procedures were performed under protocols 
approved by the Institutional Animal Care and Use Committee of the University of 
Connecticut and conform to US NIH guidelines. The dissected tracheas were 
 
Figure 5-5: Proposed role of Dyx1c1 in the cytoplasmic assembly pathway. 
Dyx1c1 interacts with the chaperones and intermediate as well as light chain dynein 
subunits in the cytoplasm. The heavy chains are added onto the intermediate chains 
and the light chains are further incorporated into the outer dynein arm complex in the 
presence of Dyx1c1 and other assembly factors.  
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transferred to a separate tube containing deciliation buffer, and incubated for 10 
min with intermittent mild vortexing. The supernatant was collected in a separate 
tube, and the procedure was repeated twice. The tracheas were then separated 
from the supernatant, the three washings were pooled, and after pelleting cell 
debris at 800xg, the ciliary axonemes were collected by centrifugation at 
20,000xg. Ciliary axonemal pellets were resuspended gently in 30 mM Hepes 
(pH 7.3), 1 mM EGTA, 0.1 mM EDTA, 25 mM NaCl, 5 mM MgSO4, 1 mM 
dithiothreitol, and 1% volume of protease inhibitor mixture (Sigma). Triton X-100 
was added (0.5%) to the suspension, and the axonemes were incubated for 15 
min on ice, followed by centrifugation. The lysates containing the axonemal 
fraction were then frozen at -80°C. The cilia-stripped-tracheas were incubated in 
RIPA buffer (Sigma) on ice for 20 min. Samples were homogenized using a 
tissue homogenizer and cleared by centrifugation at 10,000g for 10 min to obtain 
the protein lysate of the cytoplasmic fraction of the trachea. Protein 
concentrations were estimated using the BCA reagent (Pierce).  
5.5.2 Protein blots of whole trachea, cytoplasmic and axonemal lysates 
 
For whole tracheal preparation, tracheal tissues were dissected from wildtype 
and knockout mice, and carefully separated from the surrounding tissues. After 
incubation in RIPA Buffer supplemented with 1× Protease Inhibitor Cocktail 
(Sigma), samples were homogenized using a tissue homogenizer and cleared by 
centrifugation at 10,000g for 10 min. The cytoplasmic and axonemal fractions of 
the trachea were prepared as described above. Proteins were separated on 12% 
SDS- PAGE minigels and then transferred to Immobilon (Millipore) membrane for 
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protein blotting. For detecting DYX1C1 protein, the antibody to N-terminal 
DYX1C1 (Sigma, SAB4200128) was used at a dilution of 1:200; antibody to 
acetylated tubulin (Sigma, T6793) was used at a dilution of 1:2000; and antibody 
to GAPDH (Sigma, G8795) was used at a 1:1,500 dilution as a loading control. 
LI-COR Odyssey infrared secondary antibodies (goat antibody to mouse 680 
(926-32220), goat antibody to mouse 800 (926-32210), goat antibody to rabbit 
680 (926-32221) and goat antibody to rabbit 800 (926-32211)) were used at 
dilutions of 1:15,000. All blots were imaged and analyzed using a LI-COR 
Odyssey Scanner and Software.  
5.5.3 Plasmids  
 
To construct Dnal1 and Dnal4 expression plasmids, cDNAs of Dnal1 and Dnal4 
respectively were amplified by PCR (Platinum Hi-Fidelity TaqDNA polymerase, 
Invitrogen) from cDNA clones (BioSource). Dnal1 and Dnal4 sequences were 
further amplified using primers incorporating flag and myc epitope tagged 
sequences respectively and then subcloned into pCAG vector to create pCAG-
Dnal1-flag and pCAG-Dnal4-myc plasmids. The GFP fused full length (pCAG-
Dyx1c1-GFP) and deletion constructs of Dyx1c1 (pCAG-ΔTPR-GFP and pCAG-
Δp23-GFP) were constructed as described previously124. The pCAG-GFP 
plasmid was used as a control. The flag-tagged DNAAF1, DNAAF2 and DNAAF3 
plasmids were a gift from Dr. Heymut Omran. The sequence of all plasmids was 
confirmed by sequencing.  
5.5.4 Cell culture and transfection 
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Human embryonic kidney (HEK293T) cells were grown to confluence in DMEM 
supplemented with 10% FBS, 1% non-essential amino acid (NEAA) and 1% 
penicillin-streptomycin antibiotics (Invitrogen). Cultures were plated at a density 
of 106 cells on a 10-cm petridish. DNA (24 µg) was added to the petridish with 75 
µl of Lipofectamine 2000 reagent (Invitrogen) in OptiMEM-1. The transfection mix 
was added to cells in normal growth media and incubated for 48 h at 37 °C. To 
obtain the protein lysates from the cells, the normal growth media was removed 
and the cells were washed with PBS. The cells were then collected, centrifuged 
to pellet the cells and the pellet was incubated in RIPA buffer supplemented with 
1X Proteinase Inhibitor Cocktail for 20 min on ice. The lysates were then 
centrifuged at 2000xg to pellet the debris. Protein blots were also performed on 
the transfected cells as described above. 
5.5.5 Immunoprecipitation 
 
Immunoprecipitation assays were performed using the Dynabeads Protein G 
Immunoprecipitation kit (Invitrogen). Briefly, Dynabeads were resuspended in the 
vial and separated on a magnet from solution. Antibody to Dyx1c1 (Sigma, 
SAB4200128), Dnal1 (Proteintech, 15809-1-AP), Dnal4 (Proteintech, 10388-1-
AP), DNAI2 (Abnova, M01, clone 1C8) or GFP (Life Technologies, A11122) (5 
µg) was diluted in 200 µl of Washing and Binding Solution and incubated with 
rotation for 120 min at room temperature. Bead-antibody complexes were 
separated on the magnet, washed by gentle pipetting and separated. Protein 
lysates were incubated with the bead-antibody complexes overnight at 4 °C. 
Bead-antibody-antigen complexes were then washed using the washing solution 
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three times. Complexes were then incubated with elution buffer for 10–15 min to 
dissociate them. Beads were separated on a magnet, and supernatant containing 
the proteins was separated by SDS-PAGE and analyzed by protein blotting using 
monoclonal antibody to DNAI2 (Abnova, M01, clone 1C8; 1:500 dilution), 
antibody to DNAI1 (Proteintech, 12756-1-AP; 1:500 dilution), antibody to Hsp70 
(BD Biosciences, 610607; 1:1,000 dilution), antibody to Txndc3 (Proteintech, 
13586-1-AP, 1:500), antibody to Hsp90 (BD Biosciences, 610418; 1:1,000 
dilution), antibody to CCT4 (Aviva Systems Biology, ARP34271_P050; 1:500 
dilution), antibody to CCT3 (Proteintech, 10571-1-AP; 1:500 dilution), anti- body 
to CCT5 (Proteintech, 11603-1-AP; 1:500 dilution), antibody to CCT8 
(Proteintech, 12263-1-AP; 1:500 dilution), c-myc antibody (Sigma, C3956, 1:500 
dilution), c-myc antibody mouse monoclonal (Sigma, M4439, 1:750 dilution), 
antibody to flag produced in rabbit (Sigma, SAB1306078, 1:1000 dilution), and 
mouse monoclonal anti-flag antibody (Sigma, F4042, 1:500 dilution). Rabbit IgG 
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6. SUMMARY  
 
This dissertation is focused on characterization of the developmental role of 
Dyx1c1. In this chapter, I will summarize the significance of my results and 
discuss the role of Dyx1c1 in the axonemal dynein preassembly process, 
followed by a detailed discussion of the unanswered questions.  
6.1 Summary of Chapters 2,3 and 4 
In the present study, reverse genetics approach has been successfully applied to 
assess the function of a candidate dyslexia gene Dyx1c1. We identified that 
Dyx1c1 knockout mice generated by the deletion of exons 2, 3 and 4 of Dyx1c1 
causes an absence of the Dyx1c1 protein. The mutation in Dyx1c1 in mice leads 
to PCD-like symptoms of hydrocephalus and situs inversus. Investigation of the 
mutant embryonic node revealed abnormalities as evident from the deposition of 
vesicle-like structures on the nodal surface in addition to monocilia; indicative of 
ciliary dysmotility. The ependymal cilia of the brain ventricles were examined by 
videomicroscopy and Indian ink assay to find mutant cilia completely immotile. 
Ultrastructural analysis of these mutant cilia further revealed the absence of two 
components of the motile cilia critical for ciliary motility, outer and inner dynein 
arms, missing from the mutant ciliary axoneme. Similar PCD-associated 
phenotypes were found in the Dyx1c1 mouse mutant, zebrafish knockdown and 
human PCD patients160. Thus, Dyx1c1 is an evolutionarily conserved protein 
essential for the motility of cilia. This gene is speculated to be important for 
formation of the outer and inner dynein arms in the cytoplasm, or their transport 
and binding to the microtubules in the axoneme.  
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Given the loss of identifiable IDA and ODA in Dyx1c1 mutant cilia, we analyzed 
the subcellular localization of Dyx1c1 and observed that Dyx1c1 localized to 
apical cytoplasm of the respiratory epithelial cells. These results led us to the 
hypothesis that Dyx1c1 is required for the cytoplasmic pre-assembly of axonemal 
dyneins. The Dyx1c1 mutation affected the localization of axonemal components 
of motile cilia. No expression of ODA DNAI2 and DNAH5 was detected by 
immunofluorescence in Dyx1c1 mutant cilia of the mice and PCD patients. To 
obtain insights into Dyx1c1 function, we further defined the interactome of 
Dyx1c1 by immunoprecipitation and mass spectrometric analysis. Endogenous 
Dyx1c1 complexes were isolated by immunoprecipitation from wildtype tracheal 
lysates and tandem MS/MS analysis was performed on the immunoprecipitates 
to find that the Dyx1c1 interactome was enriched for the proteins in the 
categories of chaperones and cytoskeletal proteins. Previously known interactors 
of Dyx1c1 such as Hsp70 and Hsp90 were identified by MS screen. In addition, a 
group of T-complex chaperones (CCTs), with a known role in ciliogenesis, were 
also identified as interaction partners of Dyx1c1. Furthermore, Dyx1c1 interacted 
with a protein of the transition zone, Sept2, known to mediate the control of 
protein trafficking into and out of the ciliary axoneme. Immunoprecipitation and 
immunoblot analysis confirmed the interaction of Dyx1c1 with these newly 
identified interaction partners. The interactions were also validated in 
heterologous expression system; and it was further demonstrated that the TPR 
domains mediated the interaction of Dyx1c1 with the Hsp70 and CCTs, while the 
p23 domain was sufficient for interaction with Hsp90.  
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The cytoplasm of the ciliated cells supposedly accumulates the assembled 
precursor ODA/IDA motor complex prior to its transport into the axoneme. 
Information about the assembly state of the ODA/IDA in the Dyx1c1 mutant 
would thus be apparent by analyzing the cytoplasmic extract of the mutant 
cytoplasm. Hence we performed deciliation of the wildtype and knockout trachea 
to obtain axonemal fraction and deciliated tracheal fraction and assessed the 
cytoplasmic abundance of the dynein arm subunits. Western blot analysis with 
antibodies against components of outer dynein arms (DNAI1, DNAI2, DNAL1, 
DNAL4) and inner dynein arms (DNALI1) exhibited a reduction in the abundance 
of these subunits in the knockout tracheal cytoplasmic fraction compared to the 
wildtype. The decrease in the dynein subunits is suggestive of a faulty dynein 
arm assembly in the cytoplasm due to either altered degradation of the 
unassembled dynein subunits or decreased synthesis of the subunits. These 
results suggested a role of Dyx1c1 in the chaperone-dependent assembly of the 
dynein arms by assisting in the folding and stability of the individual dynein arm 
subunits or aiding in the incorporation of the subunits into a functional motor 
complex. Alternatively, the data suggest that Dyx1c1 might be required for the 
stability of the assembled dynein motor complex and trafficking to the base of the 
cilium at the transition zone.  
A novel PCD-causing mutation in Dyx1c1 (p.L19Q) was recently identified in an 
inbred Druze population of Israel. This mutation was identified in the p23 domain 
of the Dyx1c1 protein and hence it was interesting to characterize this mutant 
biochemically. The patients suffered from the above-mentioned classic PCD 
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symptoms and lacked the expression of the ODA intermediate chain DNAI1 as 
well as the IDA chain DNALI1 from the mutant axoneme. Immunoblot analysis of 
the patient respiratory epithelial protein lysates demonstrated that the Dyx1c1 
protein was expressed in the PCD patients at the correct size as were the 
proteins Sept2 and Ktu. However, intriguingly the interaction of Dyx1c1 with 
Setp2 and Ktu was reduced by more than half in the presence of the mutant 
compared to the control condition. Additional analysis of the dynein subunit 
abundance exhibited decreased expression of the ODA subunits DNAI2 and IDA 
subunit DNALI1; indicative of a defective pre-assembly of the dynein arms, thus 
strengthening our claim that Dyx1c1 is a cytoplasmic pre-assembly factor.  
Outer arm dynein assembly is a multistep process that involves preassembly of 
subunits in the cytoplasm, movement of complexes into flagella, and assembly of 
these complexes into a functional dynein arm (Fig. 6-2). 
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Most mutations that disrupt this process have been traced to genes encoding 
subunits of the dynein motor itself, or cytoplasmic assembly factors of axonemal 
dyneins, or subunits of complexes that form binding sites for motor attachment. 
Cytoplasmic preassembly of dynein HCs has been found to require at least two 
steps61. The first step involves the folding of the globular dynein head domain, 
which is required for HC stability. DNAAF1 and DNAAF2 contribute to this step 
Figure 6-2: Schematic of the cytoplasmic pre-assembly of the outer dynein arm. 
The outer dynein arm subunits are synthesized and transported to the base of the 
cilium at the basal body region. These subunits are then assembled together into a 
functional outer dynein arm in the presence of the chaperones and assembly factors. 
The assembled complex is docked onto the IFT particles for their transport into the 
axoneme and later attached to the microtubules. (Adapted from Fliegauf et al. 2008) 
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together with HSP70. The second step involves formation of the HC–IC complex, 
which requires DNAAF3 (Fig. 6-3). Further experiments are needed to 
understand the specific role of Dyx1c1 in the assembly process.  
 
Our biochemical analyses provided important insight into the proposed function 
of Dyx1c1 as a facilitator of dynein pre-assembly, by revealing defects in the 
interaction of intermediate and light chains in the cytoplasm. Immunoprecipitation 
experiments demonstrated an interaction between Dyx1c1 and the intermediate 
                  
Figure 6-3: Schematic of the proposed outer dynein arm pre-assembly in the 
presence of the cytoplasmic assembly factors. The heavy chains require the 
action of DNAAF1, DNAAF2 and DNAAF3 for the proper folding of their head 
domains and their stability. These assembly factors may also contribute to later steps 
in which heavy chains associate with intermediate chains. We hypothesize that these 
assembly factors work with a chaperone complex (labeled with a question mark). 
(Adapted from Mitchison et al. 2012) 
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chains, Dnai1 and Dnai2 as well as the light chains Dnal1 and Dnal4 in the 
cytoplasm of tracheal epithelial cells. Furthermore, the association of Dnai1 to 
Dnai2 and Dnal1 to Dnal4 was reduced in the mutant tracheal cytoplasm 
compared to the wildtype. The assembly of the intermediate to light chains was 
also found to be disrupted in the mutant cytoplasm. Heterologous experiments in 
transfected HEK cells showed that the light chains interacted with Dyx1c1 via the 
TPR domains of Dyx1c1. Interestingly these domains are previously identified to 
be important for Dyx1c1 role in neuronal migration as well as interaction with 
Hsp70 and CCTs. When the interaction of the light chains Dnal1 and Dnal4 was 
investigated, we found that Dyx1c1 was necessary to induce the interaction of 
the light chains. Intriguingly, both the domains of Dyx1c1 were required for the 
light chain association. Furthermore, the interaction of the light chains could be 
induced partially in the presence of Ktu/DNAAF2 but with the other assembly 
factors DNAAF1 or DNAAF3.  
6.2 Cytoplasmic preassembly of axonemal dyneins 
To understand the cytoplasmic preassembly process and specifically the role of 
Dyx1c1 in it, the following questions need to be addressed.  
6.2.1 Which ultrastructural components does Dyx1c1 localize to? 
Cilia are complex organelles requiring the proper functioning of several proteins. 
Electron microscopy has been useful in providing a detailed knowledge of the 
ciliary ultra structure. It is necessary to comprehend the specific macromolecules 
that contribute to the ciliary structures. Hence, to characterize the role of Dyx1c1 
in the cytoplasmic preassembly in greater detail, it would be interesting to identify 
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the subcellular structures that associate with Dyx1c1 to pinpoint the pathway of 
Dyx1c1.  Future studies performed using the immunoEM technique could assist 
in analyzing the ultrastructural localization of Dyx1c1 in ciliated cells. It could be 
speculated that since Dyx1c1 plays a role in the cytoplasmic preassembly of the 
dyneins, it would be localized at the base of the cilia around the basal bodies. 
Alternately, Dyx1c1 would be arranged almost linearly from the base of the cilia 
to the transition zone suggesting a function of Dyx1c1 in dynein arm transport. 
Studies have shown that Dyx1c1 interacts with chaperones and if Dyx1c1 were 
to function in protein folding or quality control, immunoEM would be able to 
detect its localization to the ER. The results obtained from these experiments will 
help us understand the role of Dyx1c1 in cytoplasm.   
 
6.2.2 Is Dyx1c1 necessary for folding/stability of dynein subunits?  
Our results show that the axonemal dynein subunits are reduced from the 
cytoplasm of the Dyx1c1 knockout trachea; thus indicating a role of Dyx1c1 in 
folding and/or stability of the axonemal dyneins. To determine if Dyx1c1 plays a 
role in the chaperone dependent assembly of the dynein arms, trypsin sensitivity 
assays could be performed to examine the folding state of the dynein subunits in 
the cytoplasm of the mutant. The abnormally folded chains would show an 
increased sensitivity to tryptic proteolysis in the KO indicating that Dyx1c1 
functions in chaperoning steps that aid in the folding of those subunits. Abnormal 
protein folding leads to rapid degradation of the misfolded proteins, which would 
lead to reduction in their abundance. If the subunits are misfolded and are getting 
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depleted from the cytoplasmic pool due to higher rates of degradation, protein 
turnover rates could be examined by blocking protein synthesis using 
cycloheximide and probing for dynein subunit-specific antibodies.  
6.2.3 Can Dyx1c1 re-expression rescue the ciliary immotility in the KO? 
RNAi studies found that knockdown of Dyx1c1 caused abnormal cortical 
migration in rat neocortex, while overexpression of full-length Dyx1c1 lead to the 
rescue of the phenotype. Dyx1c1 deficiency leads to loss of ciliary motility and 
therefore, overexpression of Dyx1c1 in KO ciliated cells will be interesting to 
assess for the rescue of the immotility phenotype. The rescue experiments would 
also provide important insights into the assembly state of the dynein arms thus 
aiding in the understanding of the assembly process.   
6.3 Dyx1c1 and ciliogenesis 
Study in Chlamydomonas performed by our collaborators, identified an 
upregulation of Dyx1c1 during flagellar regeneration. This indicates that Dyx1c1 
might have a putative function during ciliary regeneration as well as cell stress. It 
would be interesting to evaluate the differentially expressed genes and changes 
in localization patterns of Dyx1c1 on wildtype and knockout ciliated epithelial 
cells at various time points following stress-induced ciliary sloughing (deciliation).  
6.4 Primary Ciliary Dyskinesia: Diagnosis and Treatment  
Our knowledge of PCD has greatly increased with the genotype-phenotype 
correlation being better understood and more information about diagnostic and 
therapeutic options becoming available. In the future, it would be interesting to 
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identify pharmacological targets that have the potential to assist in protein 
expression and in turn overcome ciliary dysfunction. Another key issue is the 
identification and confirmation of more PCD causing genes. Cilia and flagella 
require many dynein isoforms for their normal function. The dynein assembly 
factors studied to date do not seem to be responsible for the formation of all of 
these axonemal dynein complexes. Future studies may identify additional 
proteins that are involved in these cytoplasmic assembly steps. This knowledge 
is crucial to allow for the development of suitable and effective screening 
methods and therapeutic agents. 
6.5 Final Remarks 
This study emphasizes the importance of the cytoplasmic preassembly steps in 
the formation of axonemal dynein arms. Based on the results presented here, the 
cytoplasmic assembly of axonemal dynein motors requires at least three steps: 
an earlier step required for chaperone-mediated folding of the axonemal dyneins, 
next step of aggregating the intermediate and light chains of the axonemal 
dyneins mediated by assembly factors and a later step that incorporates these 
dynein chains to generate an assembly competent motor complex (Fig. 5-5). In 
conclusion, we have shown an essential role for Dyx1c1 (DNAAF4), a conserved 
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